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ABSTRACT 
Seri Anderson: The Cost-Efffectiveness of Improved Communication of Pregnancy Risk and 
Contraceptive Information 
(Under the direction of Kristen Hassmiller Lich) 
 
To prevent unplanned pregnancies, the Centers for Disease Control and Prevention 
(CDC) recommends that women receive contraceptive counseling and suggests a contraceptive 
poster that it designed as one tool to accomplish this goal. However, the CDC poster has not 
been evaluated to determine whether it improves contraceptive knowledge or intentions. 
Furthermore, it was not developed with the input of patients. This project’s overall objective was 
to fill these gaps in the literature by creating and evaluating a patient-centered poster designed to 
better communicate information about pregnancy risk and contraceptive effectiveness. My 
central hypothesis was that the patient-centered poster would be a more cost-effective and 
acceptable method of preventing unplanned pregnancies among women of reproductive age than 
the CDC poster. This project is innovative because it draws on women’s insights to develop the 
poster.  
This project’s first aim compared the comprehension, relevance, and acceptability of the 
two posters through cognitive interviews with N=26 women. The second aim compared how 
effectively the two posters changed: women’s contraceptive knowledge, the accuracy of 
women’s perceived pregnancy risk, and the effectiveness of the contraceptive methods women 
were most likely to use in the following year. We did this by conducting a randomized control 
trial of the posters in an Amazon Mechanical Turk sample of N=990 women. The third aim 
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compared the cost-effectiveness of the two posters in comparison to the status quo. To do this, 
we created two Markov models using a private payer perspective.  
In the first aim, we found that the final version of the patient-centered poster was 
preferred overall and in terms of comprehension and relevance by the majority of women. It 
generated few remaining acceptability issues. In the second aim, we found that the patient-
centered poster improved contraceptive knowledge significantly more than the CDC poster, and 
both posters significantly improved the effectiveness of women’s most likely contraceptive 
method. In the third aim, we found that both the patient-centered and the CDC poster reduced 
costs and improved health outcomes relative to the status quo. This project helps advance the 
CDC counseling recommendation and the Healthy People 2020 goal of reducing unplanned 
pregnancies. 
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CHAPTER 1: INTRODUCTION AND OVERVIEW 
Specific Aims 
In the US, unplanned pregnancies cost the public $21 billion annually [2] while harming 
the health of women and children [3]. Despite representing only 14% and 18% of the women at 
risk of an unplanned pregnancy, 54% and 41% of unplanned pregnancies occur among women 
who do not use contraception or who use it inconsistently, respectively [4]. Two key reasons [5, 
6] for inconsistent or non-use of contraception are that 40% of women greatly overestimate 
contraceptive failure rates [7], and 24% of women greatly underestimate the long-term risk of 
pregnancy associated with unprotected sex [8]. The Centers for Disease Control and Prevention 
(CDC) has a poster that is designed to educate women about contraceptive effectiveness, but its 
effectiveness has not been evaluated, and it does not provide information about women’s 
baseline pregnancy risk. Furthermore, it was not designed with the input of patients. An 
innovative, evidence-based new contraceptive poster is needed to prevent costly and harmful 
unplanned pregnancies.  
This project’s objective was to create and evaluate a patient-centered poster 
designed to better communicate information about pregnancy risk and contraceptive 
effectiveness. My central hypothesis was that the patient-centered poster would be a more cost-
effective and acceptable method of preventing unplanned pregnancies among women of 
reproductive age than the CDC poster. This work had three specific aims:  
Aim 1: Compare the comprehension, relevance, and acceptability of the CDC poster and the 
patient-centered poster among women of reproductive age. 
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Aim 2: Compare the effect of the CDC poster to the patient-centered poster on changes in 
women’s contraceptive knowledge, the accuracy of women’s perceived pregnancy risk, and the 
effectiveness of the contraceptive methods women were most likely to use in the following year. 
Hypothesis 1: In an online randomized control trial, women shown the patient-centered 
poster will increase their contraceptive knowledge, express an intention to use more 
effective contraceptive options, and increase the accuracy of their perceived risk of 
pregnancy compared to women shown the CDC poster. 
Hypothesis 1a-c: Hypothesis 2 holds for women with past pregnancy scares, low 
numeracy, and no current contraceptive method. 
Aim 3: Compare the cost-effectiveness for preventing unplanned pregnancies of the CDC poster 
and the patient-centered poster compared to the status quo, which is the current distribution of 
contraceptive methods observed in the US population. 
Hypothesis 2: Using two Markov models, exposure to the patient-centered poster will 
cost-effectively prevent unintended pregnancies compared to the status quo. 
This project’s expected outcome is the estimated cost-effectiveness for preventing unplanned 
pregnancies of both posters. This project helps advance the CDC recommendation to provide 
contraceptive education during reproductive counseling [9] and the Healthy People 2020 goal of 
reducing unplanned pregnancies [10].  
Significance 
A. Unintended pregnancies are common and harm the health of mothers and infants. 
 Unintended pregnancies comprised 45% of pregnancies in the United States in 2011 [11]. 
This means that nearly 5% of reproductive age women (aged 15-44) will experience an 
unintended pregnancy each year [11]. Unintended pregnancies are associated with poor 
outcomes for mothers [3]: delayed prenatal care [12], reduced economic stability [13], and 
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worsened mental health [14]. Unintended pregnancies are also associated with poor outcomes for 
infants [3]: premature birth [15], worsened relationships with parents [16], and reduced 
economic investment in children [13].  
B. The current approach to communicating contraceptive effectiveness encourages 
misinterpretation. 
 The CDC poster focuses on statistical and relative contraceptive effectiveness [17], as do 
most paper posters. This approach has two weaknesses. First, it does not report a pregnancy rate 
for unprotected sex. As a result, the CDC sheet may not educate the 1 in 4 women who 
underestimate the annual probability of pregnancy for unprotected sex by >15 percentage points 
[8]. Second, the sheet presents contraceptive effectiveness using one-year failure probabilities, 
which people rarely interpret accurately [18]. Consequently, the CDC poster may correct few of 
the 4 in 10 women who greatly overestimate contraceptive failure rates [7, 18]. The limitations 
of the CDC poster have real consequences: when women overestimate the likelihood of 
pregnancy with protected sex or underestimate the likelihood of pregnancy with unprotected sex, 
they are less likely to use contraception [6, 19-21]. Communication research suggests that when 
teaching people about risk, we should avoid statistical jargon and help people realize their 
behavior puts them at risk [22]. We pilot tested a poster that avoided jargon in its presentation of 
the effectiveness of each contraceptive method and no method (Aims 1-3).  
C. Research on the cost-effectiveness of contraceptive posters has significant implications for 
policy and practice. 
Reducing unintended pregnancies to 44% is a Healthy People 2020 goal [10]. Because of 
this, CDC recommends reproductive counseling at every patient contact and suggests using the 
CDC poster to educate people about contraception [9]. However, it is unknown whether this 
recommendation is cost-effective, because the effectiveness of the CDC poster has not 
previously been evaluated. This project is significant because it will 1) pilot several novel 
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methods of communicating risk that could be applied to other prevention goals, 2) test the cost-
effectiveness of the CDC poster, and 3) pilot test a new poster for preventing unplanned 
pregnancies (Aims 1-3). 
Innovation 
When women have more contraceptive knowledge they tend to use more effective 
contraception [23], but researchers do not know whether contraceptive posters are a cost-
effective educational intervention. Regardless of the outcome of this project, the results will 
influence clinical practice by providing evidence to improve CDC’s recommendations regarding 
contraceptive posters.  
Furthermore, this project is innovative because it tests several novel measures of 
probabilistic risk that could both help women rank contraceptive methods by effectiveness while 
also correcting misconceptions that increase contraceptive non-use. Finding a method of 
communicating risk that is intuitive and understandable for less numerate people would be 
advantageous for public health work in reproductive health and other preventable conditions. It is 
also innovative because it draws on the expertise of average patients to design a poster that meets 
the average woman’s communication and informational needs.  
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Figure 1.1 Contraceptive Health Belief Model 
Conceptual Model 
The conceptual model for this study is Hall’s Contraceptive Health Belief Model [24] 
(Figure 1.1). This model posits that the likelihood of contraceptive behavior is dependent on 
individual decision making, which is determined by a number of factors: the perceived threat of 
pregnancy, a contraceptive-cost-benefit analysis, and modifying and enabling factors (not 
shown). Hall demonstrates that evidence consistently supports the links between each of the 
domains in this model [24]. 
In the context of this model, Aim 1 refines the cue-to-action intervention, which is the 
patient-centered contraceptive poster. Aim 2 tests how this cue affects contraceptive decision-
making and likelihood of contraceptive behavior by changing the perceived threat of pregnancy 
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and a woman’s contraceptive cost-benefit analysis. Aim 3 makes a business case by testing how 
the posters influence costs and benefits by changing individuals’ contraceptive decision-making 
and likelihood of contraceptive behavior. 
Approach 
I will describe my approach to each aim individually. Throughout, I study women of 
reproductive age, defined as women age 18-44. 
Aim 1 
Introduction. This aim’s objective was to compare the comprehension, relevance, and 
acceptability for the two posters. My planned approach was to conduct cognitive interviews with 
approximately 20 women about the posters (Figure 1.2). The interviews occurred in several 
waves, with revisions to the patient-centered poster after each wave. The rationale was to refine 
the patient-centered poster and provide feedback to the CDC on its poster.  The expected 
outcomes were: 1) a refined patient-centered poster that was comprehensible, relevant, and 
acceptable to the majority of women, 2) suggested revisions to the CDC poster to improve 
comprehension, relevance, and acceptability, and 3) a qualitative understanding of how the 
patient-centered poster compares to the CDC poster in terms of comprehension, relevance, and 
acceptability. 
Procedures. I conducted cognitive interviews with 26 women age 18-44 living in North 
Carolina who spoke and read English and who had ever had sex. These women were recruited 
from a University email list, a women’s health research center, and a Family Medicine practice. 
We purposively sampled women to have a range of characteristics that might influence their 
perspectives. Cognitive interviewing explores breakdowns in the process of understanding and 
responding to outside information [25], and has previously been used to test comprehension of 
contraception education materials [26]. It requires an iterative cycle of revisions and 
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interviewing. I used the “think-aloud” method with semi-structured interviews to elicit responses 
to the posters [27].  
Analyses. We conducted interviews in unequal-sized waves until saturation was reached 
within the wave; we continued adding waves until we reached a wave where there were no 
suggestions warranting major revisions to the patient-centered poster. The interviews were audio 
recorded, transcribed, and coded for themes. A second researcher coded half of the interviews. 
Using the thematic codes and transcriptions, after each wave I created a structured report for 
each poster documenting issues that arose, the number of women mentioning an issue, and the 
number of mentions [25]. The summaries were used to decide what revisions to the patient-
centered poster were needed [25]. 
Limitations. The primary limitation of this study is that it only includes women who live 
in North Carolina, which limits the generalizability of the results. 
Aim 2 
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Figure 1.2 CDC and Initial Version of Patient-Centered Posters 
Average Time Until an Unplanned Pregnancy for Each 
Family Planning Method* 
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 Introduction. This aim’s objective is to compare the effect of the CDC poster to the 
patient-centered poster on changes in women’s contraceptive knowledge, the accuracy of 
women’s perceived pregnancy risk, and the effectiveness of the contraceptive methods women 
were most likely to use in the following year. I tested the working hypothesis that the patient-
centered poster would significantly improve all of these outcomes compared to the CDC poster, 
with subgroup analyses of this hypothesis among women with a previous pregnancy scare, low 
numeracy, or no current contraceptive method. My approach was to conduct a randomized 
control trial using an online national sample of approximately 1,000 women aged 18-44 who 
were sexually active with a man in the past three months, not seeking pregnancy, not pregnant, 
and who spoke and read English. The expected outcomes were pilot results on: 1) whether the 
CDC or patient-centered posters improve risk factors for unintended pregnancy, 2) whether these 
results hold for particularly vulnerable subgroups of women, and 3) whether either poster 
performs significantly better than the other. 
Data Sources. I collected primary data on N = 990 women for this aim using Amazon 
Mechanical Turk. Amazon Mechanical Turk data are generalizable to American internet users 
and have been found to be as reliable as data from other sources [28, 29]. 
Key Variables and Measures. The survey will have screening questions, a “before 
exposure” section, exposure to one of two posters, and an “after exposure” section.  
I measured current contraceptive use by asking women before exposure to a poster what 
method they used in the past three months. All other outcome variables are measured before and 
after exposure. Contraceptive knowledge was measured using the validated, 25-question 
Contraceptive Knowledge Assessment [30]. We measured contraceptive intentions by asking 
whether they 1) intend to continue using their current method and 2) rank which methods they 
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would be willing to use if they had to switch methods in the next year. To measure accuracy of 
pregnancy risk perception, women were asked whether their chances of getting pregnant this 
year were very high to very low, and this response was compared to their true risk based on their 
current contraceptive method.  
Before exposure I asked whether the woman had ever had a pregnancy scare and I 
measured numeracy using the Berlin Single-Item Numeracy scale [31]. I used standard questions 
from the National Survey of Family Growth and the National Longitudinal Study of Adolescent 
to Adult Health to measure potentially confounding variables (see Chapter 4).  
Analysis. First, we used two-sample t-tests and likelihood-ratio tests to test whether the 
confounding variables were balanced between the two randomized groups. Because there were 
no significant differences between the groups, we did not control for these variables. We also 
presented information on the distribution of similar covariates in a nationally representative 
sample: the 2013-2015 National Survey of Family Growth. We then tested whether each poster 
improved the three outcomes relative to baseline and relative to the other poster using two-
sample t-tests on the change in the mean score for each outcome. Finally, we tested the same 
hypotheses in the three subgroups: women with prior pregnancy scares, low numeracy, or no 
current contraceptive method.  
Limitations. A limitation of this study is the lack of follow-up data on women’s 
contraceptive usage. However, this project is intended as a pilot study to assess the potential of 
these posters; future research should evaluate their performance in a clinical setting. 
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Aim 3 
Introduction This aim’s objective was to estimate the cost-effectiveness of using the 
CDC and patient-centered posters to prevent unplanned pregnancies compared to the status quo. 
I tested the working hypothesis that exposure to the patient-centered poster would cost-
effectively prevent unintended pregnancies compared to the CDC poster and the status quo. My 
approach was to use two Markov models comparing the costs and benefits associated with 
contraceptive choices made after exposure to either poster or the status quo. The first Markov 
model did not simulate contraceptive switching and discontinuation, making the assumption that 
the population-level contraceptive mix is relatively stable. The second model did simulate 
contraceptive switching and discontinuation. The rationale for this study was to produce a 
business case for using these contraceptive education posters. The expected outcome was cost-
effectiveness estimates for each poster. 
Procedures. I built two Markov models in TreeAge Pro Healthcare that simulated the 
behavior of a hypothetical cohort of women who do not intend to conceive and are of 
reproductive age. Input probabilities and costs for this model were sourced from a literature 
review and Aim 2 primary data.  
Key Variables and Measures. The health outcomes for this model were number of 
unplanned pregnancies averted and quality-adjusted life years. Women chose a contraceptive 
method using the distribution in preferences observed after being exposed to each poster or at 
baseline (for the status quo) in Aim 2. After choosing a method, women could experience one of 
four possible method failures or no failure that year. In the switching model, women could 
choose to switch to a new contraceptive method at the end of the year. This cycle repeated for 
five years. We chose this time horizon because long-acting contraceptive methods have high up-
front costs, but are effective for a long period of time [1]. Costs were measured in 2017 US 
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dollars. I incorporated costs associated with method failures, contraceptive methods, and visit(s) 
for obtaining the method.  
Analysis. I calculated incremental cost-effectiveness ratios for unplanned pregnancies 
averted and quality-adjusted life years, as well as a cost-effectiveness acceptability curve [32-
34]. I will quantify uncertainty using a probabilistic sensitivity analysis [33] and a bivariate 
sensitivity analysis varying the implementation costs and effectiveness of the posters.  
Limitations. Because Aim 2 only collected contraceptive intentions rather than behavior, 
this study assumes that women’s intentions are acted on perfectly. The results are also only 
generalizable to the same population that the Aim 2 results are generalizable to; this likely means 
the internet-using population of women aged 18-44.  
Summary of Contributions 
The findings from this research provide evidence to enhance CDC’s 2014 Quality Family 
Planning recommendations regarding contraceptive counseling using contraceptive posters. This 
project also tested several novel ways of communicating probabilistic risk. This research is 
important because to achieve the Healthy People 2020 goal of reducing the number of unplanned 
pregnancies in the US, every aspect of our contraceptive counseling must help women choose 
contraception that is in accordance with their reproductive goals. We can educate women while 
preserving their right to choose the contraceptive method of their choice using simple, 
inexpensive posters like the posters tested here.  
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CHAPTER 2: LITERATURE REVIEW 
Overview 
The goal of this dissertation is to refine and pilot test a new, patient-centered 
contraceptive effectiveness educational poster and compare it to a poster created by the CDC. 
This dissertation is needed because the CDC poster does not include information to address 
common misconceptions about pregnancy risk and contraceptive effectiveness. These 
misconceptions increase the likelihood that women will have unprotected sex [19, 23, 35-38]. 
This chapter will review the literature on the prevalence, sources, and consequences of these 
misconceptions about pregnancy risk and contraceptive effectiveness. It will also give an 
overview of the currently available contraceptive posters and decision aids, as well as previous 
studies of the posters’ ability to change women’s misconceptions and improve women’s 
contraceptive behavior.  
Prevalence of Pregnancy Risk Misconceptions 
I define a pregnancy risk misconception to mean underestimating the risk of pregnancy 
with unprotected sex. A subtype of this misconception is perceived infertility: when a person 
wrongly thinks they cannot conceive. CDC reports that in 2013 about 6.1% of married women in 
the United States are infertile, meaning they are unable get pregnant after at least 12 months of 
unprotected sex [39]. However, many more than 6% of women believe that they might be 
infertile or underestimate the risk of pregnancy with unprotected sex. Between 14.6%-21.5% of 
women aged 15-29 have reported thinking that it is very likely that they are infertile on both 
large nationally representative surveys [40, 41] and single-state surveys [35, 36]. A small study 
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that I conducted using an Amazon Mechanical Turk survey of N = 242 women aged 18-44 found 
that 55% of these women thought that it was at least slightly likely that they were infertile.  
Misconceptions about the general likelihood of conceiving with unprotected sex are 
similarly common. In a national survey of 1,392 women with no history of abortion recruited at 
family planning clinics, 91% inaccurately estimated the risk of conception from having 
unprotected sex once, and 25% underestimated the probability of pregnancy associated with a 
year of unprotected sex by >15 percentage points [8]. A second study conducted through the 
Contraceptive CHOICE project found that 14% of women thought that the annual chance of 
pregnancy without contraception was <10% (an underestimate of at least 75 percentage points) 
[42]. Finally, public and private health care providers rank “underestimating pregnancy risk” as 
the second most prevalent problem among contraceptive clients [43]. In summary, at least twice 
as many women believe they are infertile as actually are infertile, and 14-25% of women 
dramatically underestimate the risk of pregnancy associated with a year of unprotected sex.  
Prevalence of Contraceptive Effectiveness Misconceptions 
I define contraceptive effectiveness misconception to mean underestimating the 
effectiveness of contraception. For reference, the CDC categorizes contraceptive methods into 
three categories based on effectiveness: very effective methods have an annual risk of pregnancy 
0-1%, effective methods have an annual risk of 2-9%, and somewhat effective methods have an 
annual risk of 10-30% [7]. Very effective methods include IUDs, implants, the hormonal shot, 
and surgical sterilization. Effective methods include birth control pills, the patch, and the ring. 
Somewhat effective methods include condoms, spermicide, and natural methods like withdrawal 
and fertility awareness.  
Many studies have shown that US women know very little about the effectiveness of 
contraception. In the “Fog Zone” national survey of 1,800 unmarried men and women aged 18-
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29, 40% of women believe that the chance of getting pregnant within a year while using the birth 
control pill is 50% or greater (true probability: 2-9%) [41]. This lack of knowledge does not 
translate into a lack of confidence: in the same study, 90% of these young adults felt that they 
had all of the information they needed to protect themselves from pregnancy [41]. In a national 
survey of 1,392 women with no history of abortion recruited at family planning clinics, only 
26% of women correctly assessed the effectiveness of condoms, 61% for the effectiveness of 
OCs, and 56% for IUDs [8]. In a study of 433 reproductive-age US women, 70% of participants 
overestimated the risk of pregnancy with a very effective method by five percentage points, and 
40% and 41% overestimated the risk of pregnancy with very effective and effective methods 
(respectively) by 15 percentage points or more [7]. Finally, a nationally representative survey of 
623 unmarried 18-29 year old women who were at risk of unintended pregnancy found that only 
50% of them received a grade of “A or B” on a contraceptive knowledge quiz, and 60% of them 
underestimated the effectiveness of the pill [23]. In summary, these studies suggest that at most 
half of women can accurately estimate the effectiveness of various contraceptive methods, 
despite the fact that more than 99% of sexually active women of reproductive age have used at 
least one method of contraception [44]. 
Sources of Misconceptions 
Studies have identified several sources of misconceptions about pregnancy risk and 
contraceptive effectiveness: a history of unprotected sex without pregnancy, alarmist sex 
education, poor communication with doctors, personal experience with contraceptive failures, 
and contraceptive failures among friends or family.  
The first reason that a woman might believe she is infertile or has a low risk of 
pregnancy is having a history of unprotected sex without conception. In a sample of 300 teen 
girls aged 14-18 from an urban population, 18% of girls who ever had a negative pregnancy test 
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result ever thought they were infertile, compared to 6% of girls who had never had a pregnancy 
test (OR 3.23, 95% CI: 1.14-9.19) [37]. A second study of 32 women split into 4 focus groups 
found that women cited a history of unprotected sex without pregnancy to justify misconceptions 
about pregnancy risk [6]. Finally, qualitative interviews with 51 unmarried from two Bay Area 
community colleges found that when a woman had a history of unprotected sex without 
pregnancy, she believed that meant that she was unlikely to ever get pregnant [5]. In particular, 
women attributed this reasoning to sex education messages warning that pregnancy is the 
inevitable result of even one unprotected sexual encounter [5].  
The second source of misconceptions about pregnancy risk is miscommunication with a 
doctor. The Fog Zone study found that 25% of the young women who believed they were 
infertile said that a doctor had told them so [41]. In a large qualitative study of women who 
received abortions at one California clinic, one researcher found that two-thirds of the women 
she interviewed said that a doctor had told them they could not get pregnant or would have 
trouble getting pregnant [45]. Since all of these women had received abortions, and thus were not 
infertile, further questioning often revealed that doctors had either told women with reproductive 
organs that vary from the norm that they “may have trouble conceiving”, or had taken women off 
of their hormonal contraceptive methods in order to test their fertility [45]. Miscommunication 
by doctors resulting in increased risk of unplanned pregnancy did not end in the 1970s: 49% of 
abortion patients in a 2003 study reported undesirable provider behaviors like being taken off of 
oral contraceptives without being given a backup method [46]. Providers who unduly worry 
women about potential infertility, or put women at risk of an unplanned pregnancy to test a 
woman’s fertility, increase the chances that women will suffer from misconceptions about her 
pregnancy risk.  
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Finally, misconceptions about contraceptive effectiveness can be attributed to how 
memorable method failures are. In a study of 32 women split into 4 focus groups, women cited 
anecdotal or personal experience with method failures to justify their misconceptions about 
contraceptive effectiveness [6]. 
In conclusion, misconceptions about pregnancy risk are likely attributable to a history of 
unprotected sex without pregnancy, alarmist sex education, and poor communication with 
doctors. Misconceptions about contraceptive effectiveness are attributable to personal 
experience with contraceptive failures or similar anecdotes from friends.  
Consequences of Misconceptions 
Misconceptions about pregnancy risk and contraception affect women’s behavior. Many 
studies confirm that when women are unlikely to use contraception if they think they are unlikely 
to get pregnant from engaging in unprotected sex. Women who think they are unlikely to get 
pregnant are 1.5-3 times as likely as other women to have unprotected sex, even when 
controlling for baseline unprotected sex, demographic factors, and psychological factors [19, 35-
38]. Women report in qualitative studies that one reason they choose to have unprotected sex is 
because of perceived infertility [6, 45]. Finally, one of the most frequently cited (40-44% of 
cases) reasons for having unprotected sex in both pregnant teens [47-50] and adult women with 
unplanned pregnancies [21, 50, 51] is perceived infertility. Furthermore, one study using 
Pregnancy Risk Assessment Monitoring System data from 7,856 women found that 66% of 
women only endorse one reason for having unprotected sex, and latent class analysis confirmed 
this finding. This suggests that misconceptions about pregnancy risk are all that is needed for a 
woman to engage in unprotected sex [51]. 
Women who underestimate the effectiveness of contraception are also less likely to use 
contraception; however, the evidence for this relationship is less strong. A national survey of 
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623 unmarried 18-29 year old women who were at risk of unintended pregnancy found that as 
their objectively-assessed contraceptive knowledge increased, the women were significantly 
more likely to use effective or highly effective birth control methods (17% increase in likelihood 
for each correct answer, p<0.01) [23]. These authors found the same association between 
knowledge and reported likelihood of having unprotected sex in the next three months (9% 
reduction in odds for each correct response, p<0.05) [23]. Finally, a study of unmarried women 
found that those who know less about the relative effectiveness of different contraceptive 
methods are less likely to use contraception [52]. However, one study which predicted previous 
unprotected intercourse found that the effect of underestimating the effectiveness of 
contraception was no longer significant after controlling for underestimating the risk of 
pregnancy, age, race, education, and perceived ease of access to birth control [19]. 
In conclusion, women who underestimate the risk of pregnancy with unprotected sex are 
much less likely to use contraception and there is some evidence that women who underestimate 
the effectiveness of contraception are also less likely to use contraception. 
Contraceptive Effectiveness Posters 
Because of the connection between contraceptive knowledge and pregnancy prevention 
behavior, the public health community has long tried to educate women about contraception. The 
CDC has recommended that every contact between women and a health care provider become an 
opportunity for education and reproductive life planning [9]. The CDC also recommends using 
contraceptive effectiveness educational tools, such as the CDC poster, during these contacts [9]. 
However, while posters explaining the effectiveness of contraception are available online, we 
were not able to identify any scientific evaluations of the effectiveness of these posters, nor were 
we able to find explanations of how they were developed.  
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On the other hand, several charts designed to communicate the relative effectiveness of 
different contraceptive methods, including a chart that seems to be the basis for the CDC poster, 
were evaluated in a previous study [7]. These charts include the FDA chart [53], the “categories” 
chart created by a group of contraceptive effectiveness researchers [7], and a chart similar to the 
CDC poster [54]. The FDA chart presents typical and perfect use rates for each method of 
contraception and no method in a table without any graphics. The “categories” chart [7] does not 
include typical or perfect use rates, but instead categorizes each method using the WHO 
categories of effectiveness and whether the method provides protection against STIs. The chart 
similar to the CDC poster combines the typical and perfect use rates with more general 
information about the broader effectiveness category that each contraceptive method falls into. It 
does not include the risk of pregnancy without a contraceptive method.  
Previous Studies on Effectiveness of Counseling Posters 
Each of these charts has strengths and weaknesses in terms of the information they 
include and the misconceptions they perpetuate. The three charts discussed previously (FDA, 
“categories”, and CDC) do not provide all of the information that a woman might need to make a 
decision about which contraceptive method to use; instead, they complement the information that 
a practitioner can provide in response to a woman’s needs and questions. A randomized trial 
conducted by Steiner et al. compared the side-by-side performances of these three charts in a 
sample of 433 women (age 18-44) recruited at five shopping malls around the US (2003). This 
trial found that the posters presenting pregnancy risk information numerically (FDA, CDC) 
increased the percent of participants who could correctly rank the pill and condoms or pill and 
hormone shot in terms of effectiveness by 14-20 percentage points [7]. On the other hand, the 
“categories” sheet poster did an even better job of improving participants’ ability to rank 
methods by effectiveness, increasing the percent with a correct response by 27-37 percentage 
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points [7]. However, while the FDA and CDC charts appear to have improved women’s ability 
to report failure rates for the contraceptive pill from 59 to 67%, the authors do not report whether 
the improvement was significant [7]. Furthermore, the “categories” chart demonstrated no 
improvement in misconceptions about contraceptive effectiveness [7]. In conclusion, all three 
charts improved women’s ability to rank methods in terms of effectiveness. However, if we want 
to educate women about actual contraceptive failure rates, then we cannot use “categories of 
effectiveness” alone, but must also provide numerical estimates of effectiveness.  
These results are supported by more general research on communicating risk information 
numerically. Humans, even those with some statistical training, have a number of biases when 
presented with probabilistic risk information. Cumulative probabilities are particularly 
problematic: when people are presented with a one-year probability of failure (as is the case in 
the FDA and CDC posters), they are unable to accurately predict how this translates to failure 
probabilities over longer periods of time [18]. Almost half of us do not predict that cumulative 
failure probabilities will increase over time [18]. The rest predict failure rates over time that 
increase too slowly and do not show large enough differences between contraceptive methods of 
different failure rates [18]. In short, even if women could accurately estimate the one-year failure 
rates for different methods of contraception, they would still be overly optimistic about 
contraceptive failure rates over multiple years and pessimistic about them over the very short 
term.  
All contraceptive posters have to fight against women’s widespread misconceptions 
about the baseline probability of pregnancy. Only the FDA chart includes the estimated risk of 
pregnancy with no method over the course of a year. However, a Cochrane review found that no 
study has tested a poster’s ability to improve women’s knowledge on pregnancy risk [55], which 
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is a clearer risk factor for contraceptive non-use than contraceptive effectiveness 
misconceptions. 
Current research suggests many ways to improve counseling posters: 
• The poster should present risk information non-probabilistically [18, 56].  
• The poster should include the risk of pregnancy with no contraceptive method.  
• The poster should also use visual cues to indicate the relative effectiveness of 
methods, since people tend to remember visual cues, not numbers [57, 58].  
• The poster should include categories of effectiveness, but not rely on only categories 
to communicate contraceptive failure rates [7].  
• The poster should present failure rates over longer lengths of time, since most women 
will use contraception for decades of their lives [18].  
• Finally, the poster should help a woman place herself into the “high risk of 
pregnancy” category or the “low risk of pregnancy” category; people’s preventive 
behavior is linked to whether they perceive themselves to be at low or high risk 
relative to other people [22, 58].  
Contraceptive counseling posters should be redesigned using the wealth of evidence available 
about how to best communication risk information.  
Finally, it is not a lost cause to rely on simple interventions like a poster to educate 
women about contraception and pregnancy. A systematic review of contraceptive education 
interventions found 21 interventions, of which nine used written materials/decision aids in either 
provider independent or enhanced settings [56]. Of these, six had a positive impact on 
knowledge [7, 59-62] and one found no impact. One of two that assessed the impact of written   
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education materials on actual contraceptive behavior found that compliance with oral 
contraceptive pill taking was increased [59]. In conclusion, written educational materials can 
improve knowledge and promote pregnancy prevention behavior.  
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CHAPTER 3: COGNITIVE INTERVIEWS TO IMPROVE A PATIENT-CENTERED 
CONTRACEPTIVE EFFECTIVENESS POSTER 
Overview 
Objectives: To refine by qualitatively comparing a patient-centered contraceptive 
effectiveness poster to a Centers for Disease Control and Prevention (CDC) poster based on 
comprehension, relevance, acceptability, design, and overall preference. 
Study Design: We conducted cognitive interviews with 26 women aged 18-44 living in 
North Carolina who spoke and read English and had ever had sex. We interviewed women about 
both a CDC and a patient-centered poster in alternating order. Participants were contraceptive 
users and non-users that we selected purposively to have a range of characteristics that might 
influence their perspective: age, race/ethnicity, previous births and pregnancies, contraceptive 
method(s) used in the past three months, pregnancy intentions, and numeracy. The initial 
response rate for participants was 55%. We coded the interviews for comprehension, relevance, 
and acceptability as defined in cognitive theory, as well as design and overall preference. We 
structured the 26 interviews into four rounds and revised the patient-centered poster after each 
round to improve these measures. 
Results: By the final round, 83% of women preferred the patient-centered poster overall, 
and it was preferred by the majority of women in terms of comprehension (86%), relevance 
(86%), and design (100%). Women raised few concerns about the acceptability of the final 
version of the patient-centered poster. Women identified many issues with both posters that the 
researchers did not anticipate, highlighting the value of patient-centered design approaches to 
educational materials.  
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Conclusions: This study refined a patient-centered poster so that its language is clear and 
it addresses the informational needs of its target audience.  
Implications: The Centers for Disease Control and Prevention and the Office of 
Population Affairs recommend that clinicians educate women about contraception. This study 
developed a poster that could help clinicians follow this recommendation. Before widespread 
implementation, more research is needed to evaluate the poster’s impact on contraceptive 
knowledge and behaviors.  
Introduction 
A Cochrane review of the effect of decision aids on helping people make health treatment 
and screening decisions found that decision aids like posters can improve knowledge and 
decision-making [9, 63]. A second systematic review of contraceptive education interventions, 
such as written materials, found that the majority improve contraceptive knowledge, and many 
can also significantly increase comfort with the decision making process and improve 
contraceptive intentions [56]. Some interventions have also demonstrated impacts on 
contraceptive use and pregnancy outcomes [56]. The Centers for Disease Control and Prevention 
(CDC) adapted an existing [7] contraceptive education poster (Figure 3.1) to help providers 
adhere to the CDC/Office of Population Affairs (OPA) recommendation that reproductive health 
counseling include contraceptive education [9]. However, while posters such as the CDC’s are 
thoughtfully developed and scientifically accurate, they may not be designed with patients’ input, 
as is recommended by the CDC and OPA [17]. When we involve patients in design, it helps 
make educational materials understandable [64], especially for the half of Americans with low 
health literacy [65]. Making health materials understandable is both a national priority, according 
to the Institute of Medicine [65], and important in sexual education specifically [17] because low 
literacy/numeracy have been associated with poor contraceptive knowledge and use [66]. We 
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used cognitive interviews to design a patient-centered poster that educates women about 
contraceptive effectiveness and their risk of pregnancy with unprotected sex; we tested this 
poster against the CDC’s contraceptive effectiveness poster. 
 
Figure 3.1 CDC-adapted Contraceptive Effectiveness Poster 
Material and Methods 
Participants 
We conducted in-person cognitive interviews with 26 women in four unequal-sized 
waves (N=4, 7, 8, and 7). Women were age 18-44, had ever had vaginal intercourse, and were 
able to speak and read English. We recruited women through a Family Medicine clinic, a 
University email list, and a women’s health research center. We used purposive sampling [67] to 
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recruit women with a range of characteristics that might influence their perspective on 
comprehension, relevance, and acceptability. These characteristics were age, race/ethnicity, 
previous births and pregnancies, contraceptive method(s) used in the past three months, 
motivation to avoid pregnancy, and numeracy (Berlin single item scale [31]). We did not provide 
compensation for participation. The University of North Carolina at Chapel Hill institutional 
review board approved this study (IRB #17-1246).  
Cognitive Interviewing Procedure 
Cognitive interviewing is a method for studying how people process and feel about 
written and graphical materials [25]. It is iterative, with rounds of interviews followed by 
refinements to the material being tested [25]. Cognitive interviewing has been used to test 
comprehension of educational materials [68-70] and contraceptive information [26].  
We presented the posters in alternating order by interview. We used the combined 
method of cognitive interviewing, which begins with the participant “thinking-aloud” [27] as 
they process a poster, and then exploring their cognitive processing further in a structured 
interview [27, 71].  
Measures 
We measured comprehension, relevance, and acceptability, the three key components of 
cognitive processing identified by Tourangeau’s cognitive theory [72] as adapted by Vreeman 
and Choi [73, 74]. We also measured design and preference. 
Comprehension is a measure with two constructs: (1) intent, whether the respondent 
understands the information presented, and (2) meaning, whether the respondent understands the 
specific words and phrases used. We assessed intent by probing whether participants could use 
the poster to correctly answer questions about contraception. We assessed meaning by probing 
whether the participant understood the key terms on each poster. 
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Relevance (Tourangeau’s “response mapping”) is a measure of whether the information 
applies to the respondent. We assessed relevance by probing whether the participant found the 
information on the poster useful.  
Acceptability (Tourangeau’s “sensitivity”) is a measure of whether the information seems 
truthful and inoffensive. We assessed acceptability by probing whether anything on the poster 
offended the participant and whether she believed the information on the poster.  
Design was assessed by asking the participant to identify missing or extraneous 
information and propose changes to the poster’s appearance.  
Preference was assessed by asking the participant to select which poster she preferred in 
terms of comprehension, relevance, design, and overall. 
Analysis  
We audio-recorded and transcribed each interview and developed a framework to code 
the interviews for our measures. Using NVivo 11, after each wave one interviewer (SA) coded 
all and a second researcher (MB) coded half of the interviews described. The kappa agreement 
scores for the two coders were 0.77 (range 0.41-0.94) for comprehension, 0.76 (0.44-0.99) for 
relevance, 0.77 (0.24-0.97) for acceptability, and 0.76 for design (0.55-0.89). The coders 
resolved discrepancies through discussion. We created an overview report for each poster 
documenting issues, the number of women mentioning an issue, and the number of mentions. 
After each round, we used the overview to revise the patient-centered poster. Our saturation 
criterion for each round was when an interview produced no new suggestions warranting serious 
modifications to the poster.  
Derivation of Contraceptive Effectiveness Measures 
The CDC poster expresses contraceptive effectiveness using the annual failure rate with 
typical use of contraception [17]. The first versions of the patient-centered poster instead used 
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the theoretical average time-to-pregnancy for each contraceptive method. We derived these from 
the annual failure rates using the binomial probability function to solve for the time at which 
there is a 50% probability of at least one pregnancy having occurred. This measure estimates the 
average time women might expect to use a contraceptive method before they have an unplanned 
pregnancy, similar to how flood risks are commonly expressed [75]. This measure assumes that 
failure rates are constant over time, which may not be the case. Later versions of the poster used 
a “times more effective” measure of contraceptive effectiveness, which is calculated by dividing 
the probability of pregnancy for unprotected sex by the failure probabilities for each method. 
This measures gives how many times more effective at pregnancy prevention a contraceptive 
method is compared to having unprotected sex 
Results 
Of the 62 eligible women we invited to participate, 34 (55%) agreed, and 26 (42%) were 
interviewed before we reached saturation. Table 3.1 provides descriptive statistics for 
participating women on key characteristics. In general, the study sample was less likely to have 
children than US women generally, more likely to use highly effective methods of contraception, 
and less likely to be in the top 50% of the population for numeracy. The majority of women were 
trying to avoid pregnancy. 
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Table 3.1 Characteristics of Interviewed Women by Interview Round  
 Round 1 
(N=4) 
Round 2 
(N=7) 
Round 3 
(N=8) 
Round 4 
(N=7) 
Total 
(N=26) 
Average Age (Years) 30.5  30.7  29.1  27.9  29.3 
Race/Ethnicity 
White 
Black 
Asian 
American Indian/Alaskan Native 
 
3 
1 
0 
0 
 
4 
2 
1 
0 
 
4 
3 
1 
0 
 
4 
0 
2 
1 
 
15 
6 
4 
1 
Any Children 
Yes 
No 
 
2 
2 
 
2 
5 
 
3 
5 
 
2 
5 
 
9 
17 
Ever Pregnant 
Yes 
No 
 
2 
2 
 
2 
5 
 
4 
4 
 
2 
5 
 
10 
16 
Method(s) Used in Past 3 Months 
Vasectomy 
Sterilization 
IUD 
Implant 
Injectable 
Pills 
Patch 
Ring 
Male Condom 
Withdrawal 
Diaphragm 
Sponge 
Spermicide 
Other 
No Method 
 
0 
0 
2 
1 
0 
3 
1 
0 
3 
0 
0 
0 
0 
0 
0 
 
1 
1 
1 
0 
0 
4 
0 
0 
3 
2 
0 
0 
0 
0 
0 
 
0 
1 
3 
0 
1 
4 
2 
1 
4 
2 
0 
0 
0 
1 
1 
 
0 
0 
4 
0 
0 
4 
0 
0 
5 
3 
0 
0 
1 
0 
0 
 
1 
2 
10 
1 
1 
15 
3 
1 
15 
7 
0 
0 
1 
1 
1 
Pregnancy Intentions 
Trying to avoid pregnancy 
Ambivalent  
Trying to get pregnant 
Don’t know 
 
2 
1 
0 
1 
 
5 
1 
0 
1 
 
5 
0 
2 
1 
 
5 
1 
1 
0 
 
17 
3 
3 
3 
Numeracy 
Top 50% 
Bottom 50% 
 
1 
3 
 
4 
3 
 
4 
4 
 
2 
5 
 
11 
15 
 
Round 1 identified simple mistakes in the patient-centered poster, leading us to reach saturation 
quickly (N=4). In the other rounds, we reached saturation within 5-10 interviews, as is typical in 
cognitive interviewing studies [27]. In Round 4, participants made few suggestions for changes 
and preferred the   
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patient-centered poster overall, leading us to conclude the study. Tables 3.2 and 3.3 show 
abbreviated versions of the overview report for each poster by round. Figure 3.2 shows the final 
iteration of the patient-centered poster. 
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Table 3.2 Abbreviated Overview Report for the CDC Poster by Domain 
Round 
1 
(N=4) 
2 
(N=7) 
3 
(N=8) 
4 
(N=7) 
Total 
(N=26) 
How Addressed by  
Patient-Centered Poster? 
Problem n* n* n* n* 
n*  
(% of N) 
COMPREHENSION: Information and words/phrases on the poster are clear 
Clinical terms (LAM, LNG IUD, nulli/parous, methods’ 
clinical names) are unclear. 
1 7 7 6 16 (62%) All removed and replaced with 
suggested non-clinical terms. 
Asterisk is not seen before the percentages, making the 
percentages confusing. 
3 2 5 2 12 (46%) Percentage legend added at the top of the 
column. 
“Typical use" is unclear. 3 4 3 2 12 (46%) Term not used. 
Pictures unclear for some methods. 2 2 4 2 10 (38%) Suggested change. 
"Permanent" is confusing when there is a small risk of 
pregnancy. 
1 1   2 (8%) “Surgical” used instead. 
RELEVANCE: Information on poster applies to the participant and is useful for her 
Missing how each method works and how long it lasts. 4 5 7 7 23 (88%) Added information. 
Missing side effects/contraindications. 1 2 3 5 11 (42%) Suggests 2nd poster. 
Women only interested in methods that are commonly used, 
relatively effective, and easy to obtain. 
 2 4 3 9 (35%) Only shows commonly used methods. 
"Family Planning" not inclusive and not equivalent to "birth 
control.” 
 3 2 2 7 (27%) “Birth control” used. 
Missing unprotected sex. 1  4 1 6 (23%) Added this information. 
ACCEPTABILITY: Information on poster seems truthful and inoffensive 
Withdrawal picture is confusing or offensive. 1 3 4 2 10 (38%) New withdrawal image. 
Pictures of sterilization offensive. 1  1 2 4 (15%) Suggested change. 
Add number to call or website. 
 1 1 2 4 (15%) Suggested change for sponsored projects 
with sponsor. 
Add "Talk to your doctor.”  1 2 1 4 (15%) Added. 
Picture of injectable is off-putting.  1 1  2 (8%) Removed needle. 
DESIGN: Poster is attractive and well-organized 
No color. 3 6 6 7 22 (85%) In color. 
Too much text/"looks" like a lot of text. 3 5 2 1 11 (42%) Text is in separate column. 
Not enough of a visual emphasis on STI prevention. 2 3 4 2 11 (42%) Bolded and in main text. 
Titles and headers are not noticed first. 1 3 3 2 9 (35%) Title is in large font. 
The order in which the information on the sheet should be 
read is unclear/Some information would not be read. 
1 3 2 3 9 (35%) Order to read information is signaled in 
design and color. 
Only the top five most mentioned issues for each category are included. *n represents the number of women who brought up that issue. 
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Table 3.3 Abbreviated Overview Report for Patient-Centered Poster by Domain 
 Round 1 (N = 4) Round 2 (N = 7) Round 3 (N = 8) Round 4 (N = 7) 
Problem n* Change n* Change n* Change n* Change 
COMPREHENSION: Information and words/phrases on the poster are clear 
Pregnancy risk measure confusing.  4 
Title 
changed. 7 
Added first-year failure 
percentages. 5 
Replaced with "times 
better" scale. 3 
No change; more prefer 
alternative. 
Pictures unclear for some methods. 2 No change. 2 No change. 4 No change. 2 Suggested change. 
Unclear what colors convey.   2 
"No method" in different 
color from other methods. 2 
Tried to reduce number 
of colors and intensity. 1 
Surgical methods now 
same color. 
Unclear what numbers mean.   2 Added explanation.   6 Header added. 
Unclear reference/scale for arrow.   2 
Added time for most 
effective.   4 
Switched scale label to 
“times more effective”. 
RELEVANCE: Information on poster applies to the participant and is useful for her 
Missing how each method works and 
how long it lasts. 2 No change. 5 
Done for all but least 
effective methods. 4 
Added information on 
least effective methods. 3 Updated IUD information. 
Missing side effects/contraindications. 1 No change. 3 No change. 3 No change. 5 Suggests 2nd poster. 
Missing brand names. 1 No change.   2 Added. 2 Added. 
Women only interested in methods that 
are commonly used, relatively 
effective, and easy to obtain.   1 
Retained all contraceptive 
options from CDC poster. 4 
Removed sponge, 
spermicide, and female 
condom. 1 Removed diaphragm. 
Missing LAM information.   1 More prefer removal. 1 More prefer removal. 1 More prefer removal. 
ACCEPTABILITY: Information on poster seems truthful and inoffensive 
Feels less believable due to no logo, 
short citation, or poor design. 3 
Added logo 
and citation. 3 Revised design.   1 No space for long citation. 
“Advertising” most effective methods. 1 No change. 3 No red, yellow, green.   1 All methods in one color. 
Add "Talk to your doctor.”   1 No change. 2 No change. 1 Done. 
Pictures of sterilization offensive. 1 No change.   1 No change. 2 Suggested change.  
Add number to call or website.   1 No change. 1 No change. 2 Suggested change. 
DESIGN: Poster is attractive and well-organized 
The order in which the sheet should be 
read is unclear/sheet is crowded.   3 
Decreased font size in 
order of importance. 7 
New layout. Fewer 
numbers.  1 
Removed diaphragm and 
technical names. 
More visual weight on STI prevention. 1 No change. 4 Bolded STI box. 3 Bolded in text.   
Titles and headers are not noticed first. 2 No change. 2 Larger title font.   1 Headers added in blue. 
More emphasis on surgical methods.   3 Retained box. 4 Separated methods.   
Too much text.   1 No change.   4 Removed surgical text. 
Only the top five most mentioned issues for each category are included. *n represents the number of women who brought up that issue. 
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Figure 3.2 Final Iteration of the Patient-Centered Contraceptive Effectiveness Poster  
In the interviews, the CDC logo was used in the Logo Space to ensure that the two posters were 
comparable. Recent research suggests that some long-acting reversible methods can be used for longer 
than they were initially approved for in some groups of women [76]; however, we use lengths of time for 
which these devices were approved for use by the U.S. Food and Drug Administration.   
  
What Are My Birth Control Options? 
Least 
Effective 
HORMONAL METHODS 
Injectable 
6% 
 
Pill 
9% 
Patch 
9% 
Ring 
9% 
SUN   MON  TUES   WED  THUR    FRI      SAT 
1 
2 
3 
4 
Most  
Effective Talk to your doctor to find a method of birth control that works best for you.  
These estimates are based on each birth control method’s observed effectiveness in the population, including 
couples using their method inconsistently or incorrectly. 
Information from CDC and Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404. 
Unprotected Sex 
85% 
Use emergency contraception 
after unprotected sex to lower 
your pregnancy risk. 
 
 
Use within: 
 
NON-HORMONAL METHODS 
Condom 
18% 
Fertility Tracking 
24% 
Withdrawal 
22% 
 
Always use condoms to  
prevent STIs. 
LONG-LASTING METHODS 
IUD 
0.2% (hormonal) 
0.8% (non-hormonal) 
Implant 
0.05% 
Get inserted by doctor into arm 
(implant) or uterus (IUD). 
 
 
Lasts up to: 
 
SURGICAL METHODS 
Vasectomy 
 
Having Tubes Tied 
 0.15% 0.5% 
Implant  
(Nexplanon®)!
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Comprehension 
Technical language was the most common issue with comprehension. Women often did 
not know the meanings of lactational amenorrhea (62%), parous/nulliparous (54%), typical use 
(46%), the LNG IUD (23%), and hysteroscopic/laparascopic/abdominal sterilization (19%). As 
one woman said:  
I think that some of it can read jargony. So it could be unapproachable. Not necessarily 
lying, but that it’s just too much.  
 
Women often assumed that the information was not relevant to them if they did not 
understand a word, and few asked for clarification. This finding led us to incorporate women’s 
preferred terminology into the patient-centered poster. For example, women suggested adding 
brand names and using “having tubes tied” instead of “female sterilization.” As one woman said: 
[The poster] broke down the names, the actual names that the doctor will usually use… 
When you're not in the medical profession, and you say, “Can I get the injectable?” and 
the doctor says, “Depo,” and you're like, “Is that same thing?”… You feel a distance 
between who you're talking to. You want to feel the same. You don't want to feel as 
though the doctor is superior.  
 
When the poster used women’s terminology it not only reduced confusion, but also 
increased the relevance of the information. 
Another consistent comprehension problem was confusion about the patient-centered 
poster’s average time-to-pregnancy measure. Women found it difficult to understand because it 
was unfamiliar and not how they thought about risk. 
I think about birth control in a very immediate way. So it's kind of hard to pick [a 
contraceptive method] out in terms of, 10 years, when would I want an unplanned 
pregnancy? That I find a little confusing when I think about this.  
 
As a result, in the fourth round we transitioned to contextualizing the percent failure rate 
with a “times more effective” scale. Women preferred this scale to the CDC’s use of a percent 
failure rate alone and were confident and accurate when interpreting it in their own words. Of the 
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five women with low numeracy in the fourth round, three preferred the “times more effective” 
scale, and one did not prefer either scale. In the final round, six out of seven women interviewed 
said the patient-centered poster was easier to understand than the CDC poster.  
Relevance 
An unexpected finding was that 27% of women felt the term “family planning” excluded 
single women or that it did not reflect their attitude when they chose contraception. One younger 
woman said: 
I don't think it should be "family planning" unless it was maybe for a couple. 
Women preferred “birth control” or “contraception,” so we use these in the patient-
centered poster.  
To increase relevance, 35% of women suggested removing uncommonly used methods 
from the poster. One woman observed: 
I don't think I have ever met anybody who uses a sponge or a diaphragm. 
In the final poster, we removed methods used by less than 0.2% of contraceptive users: 
the female condom, diaphragm, sponge, and spermicide [77].  
When the poster provided information relevant to women’s options, it increased women’s 
perceived ability to process their contraceptive choices. As one woman said in Round 3:  
[The patient-centered poster] is just more useful to me because it gives me more of what I 
need in terms of being able to make a decision about birth control. How often do I have 
to take it? What's the length of time that it will be effective for me in terms of not getting 
pregnant? ... Does it have hormones? … And how it's used. So I think that information is 
presented here in a much easier digestible frame. It's easier for me to understand. 
 
In each round, an increasing proportion of women said the patient-centered poster 
provided more relevant information than the CDC poster. By the final round, six out of seven 
women said that it was the more useful and relevant poster.  
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Acceptability 
Some women found the withdrawal (38%) and sterilization (15%) pictures unacceptable. 
One woman (W) brought her sister (S) to the interview (I), and they discussed the issue: 
I: I noticed you laughed at the withdrawal picture.  
W: Yes. Because I had to really look at it to see what was going on there. [laughs] 
I: What do you think about that one? 
W: It's really detailed. Tell you the truth I don't think it should be in there. 
S: Some people don't know. Especially if they're young. And maybe their parents don't 
talk about sex at all. 
W: But my child. I'm thinking about my child. 
S: It's not for kids. 
W: But if she be in the room with me, she's going to see that. 
Another participant said she cannot depict human genitalia when she teaches sexual 
education at her church. In response, we commissioned an artist to draw a less graphic image for 
withdrawal, which was preferred by the majority of women and raised no acceptability concerns.  
Another acceptability problem for the patient-centered poster was women’s perception 
that it was advertising highly effective methods. Black women were especially concerned about 
this, due to the history of forced sterilization in their community. As one Black woman said: 
I do get some under-the-current, subliminal messages in that the [least effective methods] 
are in red, and then the middle one is in yellow… I've done more study on forced 
sterilization, stuff like that with certain populations. It gives me the subliminal message 
that women like me shouldn't look at these [least effective] methods. And it makes me feel 
like, would the doctor forced sterilize me? Or offer me that option versus these other 
options?  
 
We reduced these concerns by replacing the term “sterilization” and putting all the 
contraceptive methods in the same color. 
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Design 
In every round, women said the patient-centered poster was more attractive than the CDC 
poster because it used color. One woman said:  
I would probably be more likely to read the colorful one [the patient-centered poster]. So 
I would like [the doctor] to have that because it's going to draw my attention. I like that 
they are making this a priority and aren't trying to just put the information out. They 
want you to look at it; they want you to pay attention to it. To me, it would tell me that my 
doctor cares about these things. 
 
The colors also helped women digest the information. According to a woman in Round 4:  
I like this because I like color-coding it this way. That way I'm actually looking at the 
entire row. I'm looking at the picture, the percentage, and then the information next to 
it… I like colors, and I feel they help direct the eyes. 
 
Over all the rounds, 85% of women asked for the CDC sheet to be more colorful, and all seven 
women in the final round said the patient-centered poster was more attractive than the CDC 
poster.  
Preference 
Table 3.4 shows the preferences of women by comprehension, relevance, 
attractiveness/design, and overall preference. Women preferred the patient-centered poster 
overall compared to the CDC poster and rated it as being more comprehensible, relevant, and 
attractive. By the final round, the only unaddressed acceptability issue with the patient-centered 
poster is that it shows male genitalia.  
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Table 3.4 Women’s Choice of Preferred Poster by Round for Each Domain 
 Round 1 (N=4) Round 2 (N=7) Round 3 (N=8) Round 4 (N=7) 
 
CDC 
Patient-
centered 
CDC 
Patient-
centered 
CDC 
Patient-
centered 
CDC 
Patient-
centered 
Comprehensible 3 1 3 4 5 3 1 6 
Relevant 4 0 7 0 3 5 1 6 
Attractive/Design 1 3 1 6 3 5 0 7 
Overall Preference 3 1 4 3 3 5 1 5 
Column Sum  11 5  15 13 14 18 3 24  
Percent of 
Round’s Total 
11/16 = 
69% 
5/16 = 
31% 
54% 46% 44% 56% 11% 89% 
Row totals within rounds do not always sum to the same number because women sometimes refused to 
voice a preference.  
 
Discussion 
Both written materials and graphical aids can provide effective contraceptive education 
[7, 56], and there are many contraceptive posters already available [78, 79]. However, to our 
knowledge, there are no studies documenting the process of developing these posters. The 
unique contribution of our study is creating a contraceptive poster using a structured process for 
incorporating women’s feedback to ensure the poster is comprehensible, relevant, and acceptable 
for the majority of women. This process is in alignment with CDC and OPA guidelines for 
developing evidence-based educational materials [9]. 
Women preferred the final version of the patient-centered poster overall and on the 
dimensions that we measured: comprehension, relevance, and design. It also raised few 
remaining acceptability concerns, especially in comparison to the CDC poster. We had a number 
of findings that may be relevant to future projects designing reproductive educational materials. 
For example, we found that women are unfamiliar with several contraceptive terms, such as 
lactational amenorrhea and LNG IUD. Testing educational posters with the intended audience 
would likely uncover technical jargon and give designers the opportunity to clarify their 
language. We also found that women are more comfortable with educational materials that do 
not depict genitalia because they worried that children might see them before their parents are 
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ready to discuss sex and sexuality with them. While it is important not to compromise 
educational value, posters may be disseminated more broadly if they have child-friendly images. 
We also found that color should not be underrated as a tool to help women process information 
and draw their attention. Practically all of the women we interviewed strongly preferred that 
posters be presented in color. Finally, we found that some women were uncomfortable when a 
poster seemed to “advertise” highly effective contraception. Women preferred a neutral approach 
when being given educational information. 
This study has several limitations. First, our study may have limited generalizability to 
US women because all interviews were conducted in North Carolina. Second, many of our 
participants used highly effective methods of contraception, which may bias our findings. 
However, we intentionally included participants that were users of less effective contraceptive 
methods, racially and ethnically diverse, and low-scoring in numeracy.  
This study highlights a number of areas for future research. Our results suggest that low-
numeracy women may prefer a “times more effective” scale for communicating contraceptive 
effectiveness. This finding should be quantitatively tested in larger, nationally representative 
samples of women. Future studies might also incorporate the preferences of health care providers 
into educational posters, who have important insight about women’s potential misunderstandings 
and gaps in knowledge. Before implementing this poster in practice, future studies should also 
evaluate the impact of the patient-centered poster on contraceptive knowledge and reproductive 
health outcomes to ensure that the poster is accomplishing its intended goal. The poster should 
eventually be studied in a clinical setting, where it would actually be distributed.  
When women underestimate the effectiveness of contraception or their risk of pregnancy 
with unprotected sex, they are less likely to use contraception [23, 35, 36, 40]. Therefore, posters 
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that clearly communicate contraceptive information could be a valuable tool to help achieve the 
Healthy People 2020 goal of reducing unplanned pregnancies [10]. The women in our study 
valued information about contraception and spoke highly of doctors and organizations increasing 
access to such knowledge.  
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CHAPTER 4: A RANDOMIZED CONTROL TRIAL OF TWO CONTRACEPTIVE 
EFFECTIVENESS POSTERS 
Overview 
Objective: To test the comparative effectiveness of the Centers for Disease Control and 
Prevention’s (CDC) standard educational contraceptive effectiveness poster and a new, patient-
centered poster on reducing risk factors for unplanned pregnancies. 
Methods: In a randomized control trial, women were presented with either the CDC or 
the new poster. Women were eligible if they were aged 18-44, could speak and read English, 
were not trying to conceive or currently pregnant, and had engaged in vaginal intercourse in the 
past three months. Data were collected in an online survey administered through Amazon 
Mechanical Turk. Baseline and immediate follow-up data were collected on the following 
primary outcomes: contraceptive knowledge (measured using the Contraceptive Knowledge 
Assessment), perceived pregnancy risk, and the effectiveness of the contraceptive method the 
woman intended to use in the following year. Pre-specified subgroup analyses were conducted in 
women with prior pregnancy scares, low numeracy, and no current contraception. Within and 
between group differences were compared among equally balanced groups.   
Results: From January 26 to February 13, 2018, 2,930 people were screened and 990 
randomized. Both posters significantly improved contraceptive knowledge relative to baseline 
(CDC +3.6, patient-centered +6.4 percentage points, p<0.0001), and the patient-centered poster 
was significantly more effective than the CDC poster at improving contraceptive knowledge 
(p<0.0001). Both posters also significantly improved the effectiveness of the contraceptive 
method that women intended to use by three percentage points relative to baseline (p<0.01 for 
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patient-centered, p<0.001 for CDC). This is equivalent to 9 out of every 100 women who viewed 
a poster improving the effectiveness of their intended contraception. 
Conclusion: This study suggests that both posters could be used to educate women about 
contraception and may reduce the risk of unplanned pregnancy by improving contraceptive 
intentions. The patient-centered poster performs better at increasing contraceptive knowledge.  
Clinical Trial Registration: ClinicalTrials.gov, www.clinicaltrials.gov, NCT03372369. 
Introduction 
Increased contraceptive knowledge is associated with taking steps to reduce the risk of 
unplanned pregnancy, including using highly effective contraceptive methods [23]. However, 
contraceptive knowledge among US women is low; at least half underestimate the effectiveness 
of contraception for pregnancy prevention [7, 8, 23, 41]. For family planning services, the 
Centers for Disease Control and Prevention (CDC) recommends that clinicians educate patients 
about contraceptive effectiveness and refers to their own contraceptive effectiveness poster as a 
potential educational tool [9]. 
Specific dimensions of reproductive health knowledge that are associated with 
inconsistent or non-use of contraception include underestimating the overall likelihood of 
pregnancy with unprotected sex [40-42] and underestimating personal risk of pregnancy with 
unprotected sex [35, 36, 40, 41]. Between 14-25% of US women underestimate the overall risk 
of pregnancy associated with unprotected sex among all women of reproductive age [43], and at 
least twice as many women believe they are very likely to be infertile [41] than are actually 
infertile [39]. The CDC’s poster may not improve knowledge of the risk of pregnancy with 
unprotected sex because it does not include this information. Furthermore, the CDC poster’s 
design may be difficult to interpret for women with low health literacy or numeracy (i.e., facility 
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with mathematics). The Institute of Medicine has declared designing educational materials for 
low health-literacy and numeracy populations a key public health priority [65]. 
We designed a patient-centered poster that is appropriate for women with low numeracy 
that includes information about the risk of pregnancy with unprotected sex. The objective of this 
study is to compare the effectiveness of the patient-centered poster to the CDC poster to improve 
women’s contraceptive knowledge, perceived pregnancy risk, and contraceptive preferences.  
Materials and Methods 
Our intervention compared exposure to either the CDC (Figure 4.1) or the patient-
centered (Figure 4.2) contraceptive effectiveness poster for as long as desired, with a minimum 
of one minute (average: 1.96 minutes for CDC, 1.79 minutes for patient-centered). The patient-
centered poster was developed through cognitive interviews with 26 women aged 18-44 living in 
North Carolina who spoke and read English and had ever had sex (see Chapter 3). In that study, 
the final version of the patient-centered poster was preferred over the CDC poster by women 
overall based on its ease of comprehension, relevance to their decision-making needs, and visual 
appeal.  
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Figure 4.1 The CDC’s Contraceptive Effectiveness Poster 
For this study, we used Amazon Mechanical Turk (MTurk) to select a convenience 
sample of US women aged 18-44 who spoke and read English, were not seeking pregnancy, 
were not currently pregnant, and who had engaged in vaginal intercourse with a man in the past 
three months. MTurk is an online service which allows individuals to post surveys to be 
completed for a nominal fee [80]. Data from MTurk users have been found to be as reliable or 
more reliable than data from other sources: workers have been consistently found to be attentive, 
their answers to questions consistent, and their answers no more or less truthful than in high-
quality probability samples of the general population [29]. 
We first screened potential participants for eligibility using a short survey, for which they 
were reimbursed $0.05. Eligible participants were invited to complete the full study survey and 
prevented from retaking the eligibility survey. Participants were reimbursed $3.60 upon 
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completion of the full survey, equivalent to the federal minimum wage for their time. Women 
gave their informed consent before participating in the full survey. The survey was implemented 
in Qualtrics, which automatically randomized women to equal-sized groups. The baseline data 
collection, intervention implementation, and outcome assessment were all conducted within one 
survey and the researchers were blind to assignment. The study was approved by the University 
of North Carolina at Chapel Hill Institutional Review Board (IRB number 17-2955).  
 
Figure 4.2 The Patient-centered Contraceptive Effectiveness Poster 
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This study measured change in the mean scores for three primary outcomes: 
contraceptive knowledge, effectiveness of most likely contraceptive method used in the next 
year, and accuracy of perceived pregnancy risk. We gathered baseline and follow-up measures 
for each of these outcomes immediately before and after the intervention, respectively.  
Contraceptive knowledge was measured objectively using the 25-item Contraceptive 
Knowledge Assessment [30]. This produced a score between 0 (0% correct) and 25 (100% 
correct). Our contraceptive knowledge outcome was the change in this score between baseline 
and follow-up.  
Effectiveness of most likely contraceptive method was operationalized using a woman’s 
intention to continue using her current contraceptive method and the contraceptive method she 
reported being most likely to switch to were she to change methods in the next year. This 
measure was intended to be a realistic measure of the contraceptive method that women were 
most likely to use in the next year. We first asked women at both baseline and follow-up: “Do 
you intend to use the same birth control method(s) that you are currently using for the next 
year?” If the woman said she intended to keep her contraceptive method(s), the effectiveness of 
the most effective method she used in the past three months was used as her most likely method 
of contraception. The effectiveness of contraceptive methods was scored using the following 
WHO-defined categories [7]: IUDs, implants, and sterilization were considered highly effective 
(score = 3, 0-1% annual failure rate); the pill, patch, ring, and injection were considered effective 
(2, 2-9% annual failure rate); condoms, withdrawal, fertility tracking, and other methods were 
considered less effective (1, 10-30% annual failure rate); and no method was its own category (0, 
85% annual failure rate). If a woman said she did not intend to keep her current contraceptive 
method, we used the effectiveness of the most likely alternative contraceptive she would use. We 
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measured this with the question, “If you had to change to a new birth control method in the next 
year, which of the following methods would you consider using?” Participants selected each 
method they would consider and then ranked the selected methods from most to least likely 
method. Our “effectiveness of most likely contraceptive method” outcome was the difference 
between a woman’s score at baseline and follow-up.  
Finally, accuracy of perceived pregnancy risk was assessed by comparing a woman’s 
current contraceptive method to her perceived pregnancy risk. Perceived pregnancy risk was 
measured using the following question: “What is your chance of getting pregnant this year?” 
with possible responses being very high (score = 5, annual pregnancy risk >50%), high (4, 
annual pregnancy risk 25-50%), moderate (3, annual pregnancy risk 5-25%), low (2, annual 
pregnancy risk 1-5%), and very low (1, annual pregnancy risk ≤1%). We assessed the accuracy 
of perceived risk based on the most effective birth control method a woman used in the past three 
months. In accordance with the WHO categories [7], for highly effective methods, we coded an 
accurate perception to be very low risk; for effective methods, an accurate perception was low or 
moderate risk; for less effective methods, an accurate perception was moderate or high risk; for 
no method, an accurate perception was very high risk. An accurate perception was assigned a 
score of 1 and an inaccurate perception, 0. Our accuracy in perceived pregnancy risk outcome 
was the change in this score between baseline and follow-up.  
Baseline data were collected on factors that might influence these outcomes. We 
measured prospective pregnancy intentions with the question, “Are you currently trying to get 
pregnant or avoid pregnancy?” [81] We measured past pregnancy scares by asking: “Have you 
ever had a pregnancy scare; that is, thought you were pregnant when you didn’t want to be, but 
later discovered that you weren’t pregnant after all?”  We measured numeracy using the Berlin 
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single item numeracy scale [31]. This scale has been tested and validated to show that people 
who answer this question correctly are in the top 50% of the population in numeracy [31]. Data 
were also collected on the sexes of the woman’s past sex partners, whether she had ever seen the 
poster before, and whether there were any types of birth control the woman could not use for 
health/safety or cost reasons. The following variables were measured using questions from the 
National Survey of Family Growth (NSFG): biological sex, age, whether the participant was 
trying to conceive or was currently pregnant, sexual intercourse in the past three months, 
education, time since first sex, and marital status. Finally, the following variables were measured 
using questions from the National Longitudinal Survey of Adolescent to Adult Health (Add 
Health): race/ethnicity (Wave V), income (Wave IV), relationship status (Wave IV), and health 
insurance type (Wave IV).  
We first tested whether the demographic and other factors were balanced between our 
randomized groups using two-sample t-tests and likelihood-ratio tests as appropriate. We did not 
find any statistically significant imbalances for any of the variables. We conducted two-sample t-
tests on the change in the mean score for each of our outcomes to test whether each poster 
improved the three primary outcomes relative to baseline and in comparison to the other poster. 
We used the Bonferroni correction to account for multiple comparisons. Using the same 
methods, we also tested the hypothesis that the three pre-specified subgroups (low numeracy, 
pregnancy scares, and no birth control) had greater increases in their mean scores for the patient-
centered poster versus the CDC poster. We chose these subgroups because the patient-centered 
poster was designed to appeal to the needs of these groups. Finally, because correct answers to 
some of the questions on the Contraceptive Knowledge Assessment were not given by either 
poster, we could determine the proportion of the change in contraceptive knowledge that was 
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attributable to the posters. We did this by analyzing the change in contraceptive knowledge 
separately for questions that did and did not have the correct answer provided by either poster. 
All analyses were conducted in Stata (Stata/SE 15, College Station, TX, US). 
For our power calculations, we assumed an alpha of 1% and a power of 80%. For our 
final analysis sample of N=936, comparing the two posters we can detect a 3 percentage point 
difference in mean change in contraceptive knowledge (standard deviation of 0.18 [30]), a 0.8 
percentage point difference in accuracy of perceived pregnancy risk (standard deviation of 0.05), 
and a 6 percentage point difference in the mean change in effectiveness of most likely 
contraceptive method (standard deviation of 0.35 [82]).  
Results 
Participants were enrolled between January 26 and February 13, 2018 (Figure 4.3). 
Enrollment ended when our target enrollment goals were met.   
To evaluate the representativeness of our sample, we descriptively compare the 
distributions of baseline factors in our study sample to their distribution in the 2013-2015 NSFG 
survey, weighted to represent the national population of US women who would have been 
eligible for our study. The baseline description of our study population and the 2013-2015 NSFG 
can be found in Table 4.1. We found no significant differences between the randomized groups 
on any of these baseline characteristics. However, there are a number of differences between the 
study population and the NSFG sample. The study sample appears to be more educated, more 
White, more middle-income, more likely to be cohabiting, less likely to be monogamous, more 
likely to have had female sexual partners, and less likely to be using effective methods of 
contraception.   
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Table 4.1 Descriptive Statistics for Full Sample, Randomized Poster Assignment Groups, 
and a Nationally Representative Survey 
Variable 
CDC 
Poster 
(N=466) 
Patient-
Centered 
Poster            
(N = 470) 
Total           
(N = 936) 
NSFG 2013-
2015  
(N = 3,021) 
Age (mean, min, max) 32 (18, 44) 32 (18, 44) 32 (18, 44) 31.4 (18, 44) 
Education         
Less than high school * (<1%) * (<1%) * (<1%) 11% 
High school graduate or GED 138 (30%) 130 (28%) 268 (29%) 34% 
Two year college graduate 82 (18%) 94 (20%) 176 (19%) 19% 
Four year college graduate 177 (38%) 184 (39%) 361 (39%) 23% 
Graduate or professional school 68 (15%) 59 (13%) 127 (14%) 13% 
Missing * (<1%) * (<1%) * (<1%)   
Race/Ethnicity         
White 352 (76%) 350 (74%) 702 (75%) 62% 
Black or African American 44 (9%) 35 (7%) 79 (8%) 13% 
Hispanic or Latinx 17 (4%) 21 (4%) 38 (4%) 15% 
Asian 26 (6%) 28 (6%) 54 (6%) 
11% 
Pacific Islander * (<1%) * (<1%) * (<1%) 
American Indian/Alaskan Native * (<1%) * (<1%) * (<1%) 
Some other race * (<1%) * (<1%) * (<1%) 
Multiple race 25 (5%) 31 (7%) 56 (6%) 
Yearly Household Income         
<$5k * (<1%) * (<1%) * (<1%) 5% 
$5k to $9,999 * (<1%) * (<1%) 17 (2%) 5% 
$10k to $14,999 21 (5%) 18 (4%) 39 (4%) 7% 
$15k to $19,999 19 (4%) 20 (4%) 39 (4%) 5% 
$20k to $24,999  22 (5%) 31 (7%) 53 (6%) 4% 
$25k to $29,999 33 (7%) 30 (6%) 63 (7%) 6% 
$30k to $39,999 53 (11%) 55 (12%) 108 (12%) 11% 
$40k to $49,999 62 (13%) 69 (15%) 131 (14%) 8% 
$50k to $74,999 101 (22%) 118 (25%) 219 (23%) 19% 
$75k to $99,999 72 (15%) 67 (14%) 139 (15%) 10% 
$100k to $149,999 45 (10%) 38 (8%) 83 (9%) 
21% 
$150k> 22 (5%) 13 (3%) 35 (4%) 
Health Insurance Type         
No Insurance 52 (11%) 50 (11%) 92 (10%) 
14% 
Indian Health Service * (<1%) * (<1%) * (<1%) 
Don’t Know * (<1%) * (<1%) * (<1%) *  
Work 140 (30%) 140 (30%) 280 (30%) 65% 
Union * (<1%) * (<1%) * (<1%)  
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Variable 
CDC 
Poster 
(N=466) 
Patient-
Centered 
Poster            
(N = 470) 
Total           
(N = 936) 
NSFG 2013-
2015  
(N = 3,021) 
School * (<1%) * (<1%) 12 (1%) 
 
Spouse 111 (24%) 117 (25%) 228 (24%) 
 
Parent 31 (7%) 30 (6%) 61 (7%) 
Buy Private 41 (9%) 44 (9%) 85 (9%) 
Active Duty Military * (<1%) * (<1%) * (<1%) 3% 
Medicaid 77 (17%) 83 (18%) 160 (17%) 17% 
Marital Status         
Never married 108 (23%) 107 (23%) 215 (23%) 25% 
Living with a partner 116 (25%) 126 (27%) 242 (26%) 19% 
Married 224 (48%) 216 (46%) 440 (47%) 49% 
Divorced 14 (3%) 18 (4%) 32 (3%) 4% 
Separated  * (<1%) * (<1%) * (<1%) 3% 
Widowed 0 (0%) 0 (0%) 0 (0%) 0% 
Sexual Relationship Status         
Dating exclusively 348 (75%) 380 (81%) 728 (78%) 94% 
Dating frequently, but not exclusively 31 (7%) 17 (4%) 48 (5%) 
1% Dating once in a while 24 (5%) 22 (5%) 46 (5%) 
Only having sex 43 (9%) 34 (7%) 77 (8%) 
Not in a relationship 14 (3%) 14 (3%) 28 (3%) 5% 
Missing * (<1%) * (<1%) * (<1%)   
Ever Pregnant         
Yes 284 (61%) 276 (59%) 560 (60%) 72% 
No 181 (39%) 192 (41%) 373 (40%) 28% 
Missing * (<1%) * (<1%) * (<1%)   
Parity         
0 211 (45%) 225 (48%) 436 (47%) 35% 
1 90 (19%) 88 (19%) 178 (19%) 18% 
2 104 (22%) 91 (19%) 195 (21%) 25% 
3 36 (8%) 33 (7%) 69 (7%) 15% 
4 18 (4%) 28 (6%) 46 (5%) 5% 
5+ * (<1%) * (<1%) 12 (1%) 2% 
Sex of Sex Partners         
Exclusively male 378 (81%) 360 (77%) 738 (79%) 98% 
Male and female 64 (14%) 86 (18%) 150 (16%) 2% 
Exclusively female 0 (0%) 0 (0%) 0 (0%) 0% 
Missing 24 (5%) 24 (5%) 48 (5%)   
Pregnancy Scare         
Yes 339 (73%) 351 (75%) 690 (74%)   
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Variable 
CDC 
Poster 
(N=466) 
Patient-
Centered 
Poster            
(N = 470) 
Total           
(N = 936) 
NSFG 2013-
2015  
(N = 3,021) 
No 126 (27%) 118 (25%) 244 (26%)   
Missing * (<1%) * (<1%) * (<1%)   
Age at First Sex (mean, min, max) 17.5 (7, 33) 17.3 (11, 34) 17.3 (7, 33) 17.1 (3, 40) 
Effectiveness of Most Effective Contraceptive Used 
in Past Three Months         
Highly Effective (IUD, Implant, etc.) 72 (15%) 81 (17%) 153 (16%) 37% 
Effective (Pill, Patch, Ring, Injection) 38 (8%) 45 (10%) 83 (9%) 24% 
Less Effective (Condom, etc.) 258 (55%) 246 (52%) 504 (54%) 29% 
No Method 98 (21%) 96 (20%) 194 (21%) 10% 
Missing * (<1%) * (<1%) * (<1%) 0% 
Cannot Use Some Contraceptives for Health Reasons         
Yes 75 (16%) 79 (17%) 154 (16%)   
No 391 (84%) 391 (83%) 782 (84%)   
Cannot Use Some Contraceptives Due to Cost         
Yes 122 (26%) 97 (21%) 181 (19%)   
No 80 (17%) 101 (21%) 536 (57%)   
Missing 264 (57%) 272 (58%) 219 (23%)   
Pregnancy Intentions         
Trying to get pregnant 0 (0%) 0 (0%) 0 (0%)   
Wouldn’t mind getting pregnant 36 (8%) 44 (9%) 80 (9%)   
Wouldn’t mind avoiding pregnancy 33 (7%) 23 (5%) 56 (6%)   
Trying to avoid pregnancy  389 (83%) 396 (84%) 785 (84%)   
Don’t know 0 (0%) 0 (0%) 0 (0%)   
Missing * (<1%) * (<1%) 15 (2%)   
Previously Seen Poster*         
Yes 36 (8%) 28 (6%) 64 (7%)   
No 415 (89%) 438 (93%) 853 (91%)   
Don’t know * (<1%) * (<1%) 19 (2%)   
Numeracy         
Top 50% 211 (45%) 228 (49%) 439 (47%)   
Bottom 50% 255 (55%) 240 (51%) 495 (53%)   
Missing * (<1%) * (<1%) * (<1%)   
* Indicates cells with <10 observations 
 
Descriptive results for our outcomes can be found in Table 4.2. Both groups started with 
a score of about 66% correct on the Contraceptive Knowledge Assessment. At baseline, the 
majority of women in each poster group believed they were at very low risk of getting pregnant. 
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Only 23-24% of women had an accurate pregnancy risk perception at baseline. Finally, we saw 
high percentages of women at baseline in both poster groups (64% in CDC and 63% in patient-
centered) who reported they were likely to use no or less effective methods. 
Table 4.2 Pre- and Post-Exposure Results for Outcomes 
Outcome Variable CDC Poster (N=466) 
Patient-Centered Poster 
(N = 470) 
 Pre Post Pre Post 
Mean Contraceptive Knowledge Score  
Range: 0 to 25 
16.6  3.76 
66.4% 
correct 
17.5  3.68 
70% 
correct 
16.7  3.63 
66.8% 
correct 
18.3  3.49 
73% 
correct 
Perceived Pregnancy Risk 
Very High  
High 
Moderate 
Low 
Very Low 
 
* 
* 
72 (15%) 
127 (27%) 
252 (54%) 
 
* 
12 (3%) 
65 (14%) 
130 (28%) 
252 (54%) 
 
* 
14 (3%) 
50 (14%) 
109 (23%) 
293 (62%) 
 
* 
17 (4%) 
50 (11%) 
117 (25%) 
283 (60%) 
Accuracy of Perceived Pregnancy Risk Score  
Range: 0 to 1 
0.24  0.43 0.24  0.43 0.23  0.42 0.24  0.43 
Most Effective Acceptable Method in Next Year 
Highly Effective (IUD, etc.) 
Effective (Pill, etc.) 
Less Effective (Condom, etc.) 
No Method 
 
 
148 (32%) 
133 (29%) 
160 (34%) 
25 (5%) 
 
 
199 (43%) 
128 (27%) 
124 (27%) 
15 (3%) 
 
 
151 (32%) 
152 (32%) 
142 (30%) 
25 (5%) 
 
 
193 (41%) 
154 (33%) 
106 (23%) 
17 (4%) 
Most Likely Method in Next Year 
Highly Effective (IUD, etc.) 
Effective (Pill, etc.) 
Less Effective (Condom, etc.) 
No Method 
 
106 (23%) 
65 (14%) 
222 (48%) 
73 (16%) 
 
130 (28%) 
59 (13%) 
205 (44%) 
72 (15%) 
 
105 (22%) 
69 (15%) 
220 (47%) 
76 (16%) 
 
120 (26%) 
76 (16%) 
203 (43%) 
71 (15%) 
Mean Most Likely Method Score  1.44  1.01 1.53  1.06 1.43  1.01 1.52  1.03 
 
Many women in our sample had an inaccurately low perceived risk of pregnancy before 
the intervention (Table 4.3). The majority of women (72%) using no method believed they had a 
low or very low chance of getting pregnant in the next year, despite the fact that 85 out of 100 
sexually active non-users of contraception (or 164 of the 194 non-users of contraception in our 
study) will conceive over the course of a year [17].  
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Table 4.3 Underestimating and Overestimating Pregnancy Risk in Study Population at 
Baseline 
 Perceived Pregnancy Risk 
Effectiveness of Most 
Effective Contraceptive Used 
in Past Three Months 
Very Low 
(≤1% 
pregnancy 
risk) 
Low 
(<5% 
pregnancy 
risk) 
Moderate 
(5-25% 
pregnancy 
risk) 
High 
(25-50% 
pregnancy 
risk) 
Very High 
(>50% 
pregnancy 
risk) 
Total 
Highly Effective (IUD, etc.) 131 (86%) 10 (7%) 5 (3%) 4 (3%) 3 (2%) 153 (100%) 
Effective (Pill, etc.) 57 (69%) 20 (24%) 4 (5%) 0 (0%) 2 (2%) 83 (100%) 
Less Effective (Condom, etc.) 276 (55%) 145 (29%) 70 (14%) 10 (2%) 3 (1%) 504 (100%) 
No Method 80 (41%) 60 (31%) 43 (22%) 8 (4%) 3 (2%) 194 (100%) 
Total 544 235 122 22 11 936 
Cells with an accurate perception of pregnancy risk are bolded 
 
Table 4.4 shows the results of our main hypothesis tests. Both posters significantly 
improved contraceptive knowledge relative to baseline (p<0.0001), and the patient-centered 
poster performed significantly better than the CDC poster at improving contraceptive knowledge 
(p<0.0001). The patient-centered poster improved contraceptive knowledge scores by 6.4 
percentage points, or 1.6 additional correct questions, and the CDC poster improved scores by 
3.6 percentage points, or 0.9 additional correct questions, on average.  
Table 4.4 Results of T-Tests 
Outcome 
CDC Poster 
(N=466) 
Patient-Centered 
Poster (N=470) 
Comparison of 
Means 
Mean Change in Contraceptive Knowledge Score 
(99% Confidence Interval) 
Range: -25 to 25 
0.90***  
(0.66-1.13) 
 
1.6***  
(1.31-1.90) 
 
Patient-
centered 
preferred*** 
Percent Change 5.4 9.6  
Percentage Point Change 3.6 6.4  
Mean Accuracy of Perceived Pregnancy Risk 
Score (99% Confidence Interval) 
Range: -1 to 1 
0  
(-0.02-0.02) 
 
0.013  
(-0.01-0.04) 
 
Fail to reject 
the null 
hypothesis 
Percent Change 0 5.4  
Percentage Point Change 0 1.3  
Mean Change in Most Likely Method Score (99% 
Confidence Interval) 
Range: -3 to 3 
0.09**  
(0.02-0.17) 
 
0.09*  
(0.01-0.17) 
 
Fail to reject 
the null 
hypothesis 
Percent Change 6.3 6.3  
Percentage Point Change 3 3  
*p<0.01, **p<0.001, ***p<0.0001 to account for multiple comparisons 
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The results for the analyses testing the change in contraceptive knowledge for questions 
that were and were not addressed by the posters can be found in Table 4.5. We found a smaller 
increase in the mean percent correct for questions that were not addressed by either poster (1.8 
percentage points for CDC and 2.1 percentage points for patient-centered) as compared to 
questions that were addressed by the posters (5.8 percentage points for CDC and 11.9 percentage 
points for the patient-centered poster). The magnitude of the change in the mean score for 
questions that were not addressed by either poster did not significantly differ between the 
posters.  
Table 4.5 Results of T-tests on Analysis of Contraceptive Knowledge Score Separated by 
Whether Posters Addressed the Questions 
Outcome 
CDC Poster 
(N=466) 
Patient-Centered 
Poster (N=470) 
Comparison of 
Means 
Mean Change in Questions Addressed by Posters 
(99% Confidence Interval) 
Range: -11 to 11 
0.64*** (0.50-
0.78) 
 
1.31***  
(1.11-1.51) 
 
Patient-
centered 
preferred*** 
Percent Change 8.5 17.4  
Percentage Point Change 5.8 11.9  
Change in % Correct  68.5% to 74.4% 68.6% to 80.5%  
Mean Change in Questions Not Addressed by 
Either Poster (99% Confidence Interval) 
Range: -14 to 14 
0.26*** (0.10-
0.42) 
 
0.29***  
(0.12-0.47) 
 
Fail to reject 
the null 
hypothesis 
Percent Change 2.8 3.3  
Percentage Point Change 1.8 2.1  
Change in % Correct  64.9% to 66.6% 65.5% to 67.6%  
*p<0.01, **p<0.001, ***p<0.0001 to account for multiple comparisons 
 
Both posters improved the effectiveness of the most likely method that would be used in 
the next year compared to baseline by 3 percentage points (p<0.001) (Table 4.4); however, 
neither poster performed significantly better than the other. This increase corresponds to 9 out of 
100 women increasing the effectiveness of their most likely contraceptive method by one 
category (i.e., moving from no method to a less effective method).  
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The results in our subgroup analyses of women with pregnancy scares, low numeracy, or 
no current contraceptive method were similar for all outcomes (results available from 
corresponding author). Participants reported no harms or unintended effects. 
Discussion 
We found that both the standard educational CDC and patient-centered posters 
significantly improved contraceptive knowledge and the effectiveness of the most likely method 
of contraception used for the next year relative to baseline. The patient-centered poster was 
significantly more effective than the CDC poster at improving contraceptive knowledge. We also 
found that these increases in contraceptive knowledge were attributable to the posters 
themselves. 
These results are aligned with a Cochrane review of decision aids, which found that 
decision aids like posters could increase knowledge, help patients make decisions, and help them 
experience less conflict about those decisions [63]. A second Cochrane review [55] identified 
interventions that increased contraceptive knowledge, including two that tested educational 
tables [7] or charts [83]. These two studies reported 14 to 37 percentage point increases, 
depending on the table/chart, for two questions asking participants to select the more effective 
contraceptive method from a pair of methods [7, 83]. However, compared to past studies that 
only assessed a small number of items tailored to the intervention [55], ours comprehensively 
assessed the impact of an educational poster or chart on contraceptive knowledge. Our study also 
found significant impacts on the effectiveness of the most likely method of contraception that 
women stated they intend to use, which is more proximal to contraceptive decision-making than 
contraceptive knowledge. Our results held in subgroups of participants who had low numeracy, 
prior pregnancy scares, and who do not use birth control, who may have a greater challenge 
understanding information about contraception. We also saw these results despite participants 
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only being exposed to the poster passively and for a very short period of time, similar to what 
they might experience if viewing the posters while waiting in a clinician’s office.  
Our results are not necessarily generalizable to the general population of US women, but 
the differences between our study sample and the NSFG sample are similar to the differences 
between Americans who use the internet and the general US population [84]. In the United States 
99% of 18-29 year olds and 96% of 30-45 year olds use the internet [85]. Our study sample also 
appears to be more knowledgeable about contraception than the general population [30]; because 
of this, it is possible that our findings underestimate the impact of posters on contraceptive 
knowledge. Finally, our study does not assess the impact of these posters on actual behaviors. 
However, we did measure contraceptive intentions, which have been shown to be a good 
predictor of behavior [86, 87]. The impact of these posters on actual contraceptive choices in 
clinical practice should be studied in future research. 
Clinicians often struggle to educate their patients about the multitude of important health 
topics in the limited amount of time they have during appointments [88]. This study tested two 
inexpensive tools to educate patients about contraception independently from a provider, and 
found that they effectively increase contraceptive knowledge and intentions to use more effective 
methods of contraception. Using these posters in practice could allow doctors to spend more of 
their time answering questions about the patient’s specific contraceptive needs, rather than 
educating them on the basics of how each method works and how effective it is.  
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CHAPTER 5: A COST-EFFECTIVENESS ANALYSIS OF CONTRACEPTIVE 
EDUCATION USING THE CDC OR PATIENT-CENTERED POSTERS 
Overview 
Objectives: This study estimates the cost-effectiveness of two contraceptive effectiveness 
posters from a private payer perspective. 
Methods: Two Markov models were constructed to simulate costs and health outcomes 
associated with education using the contraceptive effectiveness posters or the status quo in a 
cohort of 10,000 women of reproductive age avoiding pregnancy. Costs used 2017 US dollars, 
while outcomes were measured using quality-adjusted life years (QALYs) and the number of 
unplanned pregnancies. Input probabilities were derived from a literature review and primary 
data gathered in a randomized control trial. The model used a 5-year time horizon. Probabilistic 
uncertainty and bivariate sensitivity analyses were conducted to examine how implementation 
variation might affect the cost-effectiveness of the posters. One Markov model simulated 
discontinuation and switching of contraceptive methods, while the other assumed no switching 
of contraceptive methods. These two models represent the previous modeling approaches used in 
the literature and provide an upper and lower bound of the effects of contraceptive switching on 
outcomes. 
Results: Both posters reduced costs and improved health outcomes compared to the status 
quo. The patient-centered and CDC posters averted 1,481 (95% CI 1479-1483) to 1,943 (95% CI 
1937-1949) and 1,558 (95% CI 1556-1560) to 1,827 (95% CI 1821-1833) unintended 
pregnancies, respectively. Both models found that the posters increased the total number of 
 59 
QALMs per woman by 0.12 (3.65 quality-adjusted life days). Total costs of intervention, birth 
control, and pregnancy per woman were reduced by $550-907 by the patient-centered poster and 
$488-705 by the CDC poster. All results were robust to the probabilistic uncertainty and 
bivariate sensitivity analyses.  
Conclusions for Practice: The use of either contraceptive poster would reduce costs and 
improve health outcomes, even if costs of implementation were high and follow-through of 
women on their intentions was low.  
Introduction 
Previous research has found that reducing the 45% of pregnancies that are unintended in 
the US [11] would both save the public money [2] and improve the health of mothers and 
children [3]. One evidence-based way to prevent unintended pregnancies is to encourage women 
who want to avoid pregnancy to use highly effective contraception when they are sexually active 
[1, 89]. When women choose highly effective contraception, it is not only a way for them to take 
control of their fertility; it is also cost-effective [1, 90, 91].  
Despite the widespread use of contraception, there is still the need for contraceptive 
education. The CDC’s recent recommendations for family planning services [9] suggest 
educating women about contraceptive effectiveness in health care visits, and highlight a 
contraceptive effectiveness poster CDC has designed as one tool for accomplishing this goal. A 
previous study by the authors (see Chapter 4) found that the CDC poster significantly improved 
the effectiveness of the contraceptive methods that women were likely to use in the following 
year. This study also tested a novel, patient-centered contraceptive poster and found that it had 
the same impact on contraceptive preferences. However, we do not know whether the effects of 
these two posters offset the costs of producing and counseling women using them, especially 
with variations in implementation effectiveness. We test the hypothesis that exposure to the 
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patient-centered or CDC posters will be a cost-effective method of preventing unintended 
pregnancies compared to the status quo even under a variety of alternative implementation 
scenarios.  
Methods 
Intervention Alternatives 
The model evaluated the costs and health outcomes associated with three alternatives: the 
patient-centered poster, the CDC poster, and the status quo. The posters changed the costs and 
health outcomes relative to the status quo by shifting the effectiveness of contraceptive methods 
that women use, a method demonstrated in a cost-effectiveness model of increased contraceptive 
coverage [92]. The status quo reflects the mix of contraceptive methods that women use without 
exposure to either poster. A previous study by the authors found that 2-8% of sexually active US 
women aged 18-44 reported having previously seen the CDC poster, suggesting that it is not 
widely used (see Chapter 4). 
Model Structure 
Figure 5.1 illustrates the structure of the models. Two Markov models were constructed 
in TreeAge Pro Healthcare (TreeAge Software, Williamstown, MA). Both use a 5-year time 
horizon and a Markov cycle length of 1 year. We chose a 5-year time horizon based on previous 
studies showing that longer-acting contraceptive methods have high up-front costs but also many 
benefits that accrue over the course of several years [1, 90]. The model structure was the same 
for all branches, but is only shown completely for one branch for the sake of brevity. A square 
decision node indicates that the entire hypothetical cohort travels down each of these branches. A 
circular chance node indicates that when women reach this node, they have a certain probability 
of entering each of the states branching off of the node, and these probabilities sum to one. In 
this model, some chance nodes are also cyclical Markov nodes. This means that when a woman 
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reaches this node, she records the outcome labeled at the node and then is put back into the 
model at the node of the same color to the left in the tree. 
 
Legend: Dashed line is only present in the switching model.  
Figure 5.1 Structure of Contraceptive Education Poster Markov Model 
After being exposed to one of the alternatives (CDC poster, patient-centered poster, or 
status quo), women can choose a contraceptive method from four categories of effectiveness 
based on the World Health Organization definitions [7]. These categories are: highly effective, 
meaning sterilization, IUDs, or implants; effective, meaning the hormonal pill, patch, ring, or 
injection; less effective, meaning condoms, withdrawal, fertility tracking, or any other method of 
contraception; and no method. After women choose a contraceptive method, there are five 
subsequent potential fertility states: no contraceptive failure, ectopic pregnancy, miscarriage, 
induced abortion, and unintended birth. In the model that does not simulate contraceptive 
switching or discontinuation, women resume using their method after experiencing one of these 
five outcomes. This approach has been used in several previous contraceptive cost-effectiveness 
models [1, 90, 92].  
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In the model that simulates contraceptive switching and discontinuation, after 
experiencing one of the five fertility states, women can choose to discontinue their method and 
switch to a new category of effectiveness. The likelihood of discontinuation is a population-
weighted average of the method-specific likelihoods of discontinuation using the most recent 
National Survey of Family Growth to derive the weights (see Table 5.1). The likelihood of 
switching to each category is the same as the probability of choosing that category initially, with 
the probability of choosing the discontinued category removed and renormalized between the 
remaining categories. Only one previous model allowed women to switch methods, and this 
model assumed that they switched to an “average” contraceptive method [93]. We chose to 
create two models, one modeling switching and the other not modeling switching, to understand 
whether there are differences in estimates of costs and benefits between the two and to increase 
the comparability of our results to previous cost-effectiveness models. Furthermore, the no 
switching model provides an upper bound on the potential effect of contraceptive method choice 
on outcomes, while the switching model provides a lower bound on this effect because it 
assumes choices reflective of the observed population, rather than women learning from 
experience. 
In summary, women in these models experience an annual cycle of being exposed to a 
poster (or no poster in the status quo), choosing a contraceptive method by effectiveness 
category, experiencing a fertility state, and (in the switching model only) either switching to a 
new contraceptive category or continuing within same category. We also programmed versions 
of the switching and no-switching model that allowed women to choose specific methods of 
contraception, rather than categories, but the results from these models were not qualitatively 
substantially different from the models reported here (see Supplement for methods and results 
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for the additional models). We did not use method-specific transition probabilities because they 
have never been previously used in the literature and because we were unable to derive reliable 
estimates of these transitions from either our trial data or secondary data sets. Small cell sizes 
resulted in a large number of highly uncertain or unstable estimates when we attempted to 
estimate method-specific transitions using these data sets. 
Key Model Assumptions 
a. The models apply to reproductive-age women (18-44) who do not intend to conceive.  
b. All women were assumed to be candidates for all contraceptive methods. 
c. Women could only use one contraceptive method at a time.  
d. In the base models, we assumed perfect implementation of the posters. In other words, 
every time a woman chose a contraceptive method she would be exposed to the poster 
and would choose a contraceptive method with the probabilities associated with that 
poster. This assumption is tested in the follow-through sensitivity analysis.  
e. Contraceptive failures other than unintended births and method discontinuations were 
assumed to occur at the midpoint of the cycle [1, 90]. 
f. Couples were assumed to have 83 acts of intercourse per year [1]. 
g. Women could only conceive once per year.  
h. We assumed that 60% of unintended births were mistimed rather than unwanted and 
would have occurred 2 years later [50]. Because of this we discounted the costs and 
benefits associated with mistimed births. 
i. We assumed contraceptive method failure occur at rates corresponding to typical use. 
Typical use failure rates included failures due to incorrect or inconsistent use by 
contraceptive users.  
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j. Transition probabilities, costs, and utilities for categories of effectiveness use the 
population-weighted average of the methods within that category, with the weights being 
the observed proportion of the population using each method in the most recent National 
Survey of Family Growth. 
k. We assumed that failure rates (by method) are constant over time.  
l. A discount rate of 3% was used for all costs and quality-adjusted life years incurred after 
1 year. 
Input Parameters  
We used parameter estimates derived from a literature review. This literature review was 
not systematic, but prioritized results that came from: 1) high-quality studies, 2) using US data, 
3) studying women of reproductive age, and 4) with recent data. Table 5.1 has probabilities for 
continuing to use each contraceptive method after one year. We use these method-specific 
continuation probabilities to calculate population-weighted averages for each effectiveness 
category. We use primary data to estimate the mix of methods used if all women were counseled 
using the new poster or the CDC poster (see Table 5.1). The primary data came from a 
randomized control trial studying a sample of sexually active, female Amazon Mechanical Turk 
users aged 18-44 who were not pregnant or intending to conceive. The expected mix of methods 
was the percentage of this sample ranking each method as the most likely method they would use 
in the next year, combining both continuation of current method and anticipated switching of 
methods. For the status quo, we applied this definition to the baseline data. These counts were 
used to parameterize a Dirichlet distribution [94].  
Table 5.2 shows probabilities of method failures and adverse events.  
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Table 5.1 Input Probabilities for Contraceptive Methods 
Method 
Method 
Failures 
After One 
Yeara 
Percent Continuing 
Use After One 
Yearb 
Pre-Intervention 
Number Using 
(N=902) (%) 
Post-Patient-
Centered Poster 
Number Using 
(N=902) (%) 
Post-CDC-Poster 
Number Using 
(N=902) (%) 
Observed 
Proportions in 
Populationc 
No Method 85% 15% 57 (6%) 35 (4%) 47 (5%) 10% 
Pill 9% 68% 116 (13%) 112 (12%) 112 (12%) 23% 
Male Condom 18% 53% 196 (22%) 154 (17%) 140 (16%) 14% 
Withdrawal 22% 43% 141 (16%) 91 (10%) 79 (9%) 4% 
Male Sterilization 0.15% 100% 80 (9%) 102 (11%) 104 (12%) 7% 
Female Sterilization 0.5% 100% 37 (4%) 53 (6%) 35 (4%) 23% 
IUD/IUSd 0.2% 80% 68 (8%) 112 (12%) 144 (16%) 7% 
Injection 6% 56% 34 (4%) 50 (6%) 34 (4%) 4% 
Patch 9% 68% 25 (3%) 37 (4%) 37 (4%) 1% 
Ring 9% 68% 31 (3%) 29 (3%) 23 (3%) 2% 
Implant 0.05% 84% 45 (5%) 71 (8%) 97 (11%) 1% 
Fertility Tracking 24% 51% 66 (7%) 50 (6%) 48 (5%) 1% 
Other Methodsc 19% 50% 6 (1%) 6 (1%) 2 (0%) 1% 
Spermicides 28% 42%    .06% 
Sponge (Parous) 24% 57%    .06% 
Sponge (Nulliparous) 12% 46%    .06% 
Diaphragm 12% 57%    .06% 
Female Condom 21% 49%    .06% 
Highly Effective Methods 0.35% 95% 230 (25%) 338 (37%) 380 (42%)  
Effective Methods 8.58% 66% 206 (23%) 228 (25%) 206 (23%)  
Less Effective Methods 19.27% 51% 409 (45%) 301 (33%) 269 (30%)  
a Source: [17] 
b Source: [95] 
c Source: [96]. Assumes that “other” contraceptive method use is equally split between diaphragm, female condoms, spermicide, and sponge. Averages the continuation and 
failure rates of “other” methods to find joint continuation and failure rates. Used to generate population-weighted averages for each contraceptive category. 
d Uses hormonal IUS continuation and failure rates [97]. 
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Table 5.2 Input Probabilities for Method Failures and Adverse Events [1] 
Method 
Ectopic 
Pregnancy 
Induced 
Abortion 
Spontaneous 
Abortion Birth Amenorrhea 
Venous 
Thrombo-
embolism 
Urinary 
Tract 
Infections 
Postoperative 
Complications 
No Method 0.01 0.4554 0.1683 0.3663     
Spermicides 0.01 0.4554 0.1683 0.3663   0.31  
Withdrawal 0.01 0.4554 0.1683 0.3663     
Fertility Awareness 
Methods 0.01 0.4554 0.1683 0.3663     
Sponge 0.01 0.4554 0.1683 0.3663     
Diaphragm 0.01 0.4554 0.1683 0.3663   0.31  
Male Condom 0.01 0.4554 0.1683 0.3663     
Female Condom 0.01 0.4554 0.1683 0.3663     
Pill 0.01 0.4554 0.1683 0.3663 0.03 0.00005 0.15  
Patch 0.01 0.4554 0.1683 0.3663 0.001 0.00005   
Ring 0.01 0.4554 0.1683 0.3663 0.03 0.00005   
Injection 0.01 0.4554 0.1683 0.3663 0.4    
IUS/IUDa 0.5 0.23 0.085 0.185 0.2    
Implant 0.01 0.4554 0.1683 0.3663 0.222    
Female Sterilization 0.33 0.3082 0.1139 0.2479    0.012 
Male Sterilization 0.01 0.4554 0.1683 0.3663    0.00043 
a Uses hormonal IUS rates [97]. 
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Costs 
Costs for private payers associated with contraception included those for the 
contraceptive method itself, physician services, method failures, and adverse events [1] (Table 
5.3). The costs of adverse events were weighted by their likelihood and incorporated into the 
total cost of each method. Direct non-medical costs and indirect costs are not included in the 
model. The costs of the interventions are uncertain, so we incorporate the uncertainty into the 
model by parameterizing the cost per woman of the intervention using a uniform distribution 
from $1-$500. A previous cost-effectiveness study of a national media campaign to educate 
people about colorectal cancer screening found that the costs per person screened were $0.12-
$2.44, so our estimate is likely high [98]. All costs were adjusted to 2017 US dollars using the 
medical care services or physician services component of the Consumer Price Index as 
appropriate [99]. Finally, we derived costs for each category of effectiveness using population-
weighted averages of the costs for each method included in that category (see Supplement for 
method-specific costs).  
Utilities 
Utilities are measured using quality-adjusted life years (QALYs) and the natural unit 
outcome of the number of unintended pregnancies averted. QALYs are a commonly used 
outcome measure in comparative effectiveness research that incorporates morbidity and 
mortality into a single measure [32]. A QALY is an abstract concept representing one year of life 
in perfect health. To calculate QALYs, we have to associate each event with a utility, which is a 
score reflecting an individual’s preference for a health state [32]. These scores range from zero – 
representing death – to 1 – representing perfect health [32]. We sourced utilities from our   
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literature review (Table 5.4) and derive a utility for each category of effectiveness by using a 
population-weighted average of the utilities of the methods within that category. Only two 
categories are reported because the other two have the default utility of 1.  
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Table 5.3 Cost Inputs for the Models 
Treatment or Outcome and Code Cost Model 
Cost 
Distribution Notes Source Source 
Year 
CONTRACEPTIVE CATEGORIES 
Highly Effective Methods 
(First Year Only) 
$2,679.27 $2,679.27  Gamma Population-weighted average of 
method costs 
Raw Range: $1,381.74-
$4,697.29 
Shapec: 10.03 
Scalec: 267.01 
Calculation  
Effective Methods 
(Annually) 
$1,004.29 $1,004.29  Gamma Population-weighted average of 
method costs 
Raw Range: $557.62-$2,414.66 
Shapec: 4.49 
Scalec: 223.47 
Calculation  
Less Effective Methods 
(First Year Only) 
$65.78 $65.78  Gamma Population-weighted average of 
method costs 
Raw Range: $14.83-$466.54 
Shapec: 0.33 
Scalec: 201.87 
Calculation  
Less Effective Methods  
(Annually) 
$63.47 $63.47 Gamma Population-weighted average of 
method costs 
Raw Range: $12.82-$461.73 
Shapec: 0.31 
Scalec: 206.62 
Calculation  
No Method $0 $0       
HEALTH OUTCOMES 
Birthg $17,958 $18,885.14 Gamma Raw Range: $16,996.41 - 
$20,773.86 
Mean: $18,885.14 
Shapec: 384.07 
Scalec: 49.17 
[100] 2015 
Induced Abortionh $535.45 $626.18 Gamma Raw Range: $186.18 – 
$2,319.14 
Mean: $626.18 
Shapec: 1.32 
[101] 2011 
  
7
0
 
Treatment or Outcome and Code Cost Model 
Cost 
Distribution Notes Source Source 
Year 
Scalec: 472.82 
Spontaneous Abortioni $535.45 $626.18 Gamma Raw Range: $186.18 – 
$2,319.14 
Mean: $626.18 
Shapec: 1.32 
Scalec: 472.82 
[101] 2011 
Ectopic Pregnancy (DRG 378)j $10,613 $14,075.85 Gamma Range: ±10% 
Mean: $14,075.85 
Shapec: 384.16 
Scalec: 36.64 
[1] 
[92] 
2005 
2015 
ADVERSE EVENTS 
Urinary Tract Infection $97.29 $119.98   [1] 2007 
Venous Thromboembolism $10,291 $15,472.71  Upper Range: $26,183 [102] 2004 
Amenorrhea $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Postoperative Complications - 
Vasectomy 
$144      
Postoperative Complications – Tubal 
Sterilization 
$5210      
a Costs are reported as average wholesale price (AWP). In the model, cost inputs are AWP-15% [1].  
b Costs are weighted by the likelihood of an adverse event occurring. 
c Assumes raw range is a 95% confidence interval around stated mean to derive standard deviation. 
d Trussell, Lalla, et al assume that 0.2% of vasectomies are performed inpatient, 77.1% in a physician’s office, and 22.7% as hospital outpatient [1, 104]. An 
updated source found that in 2001, 78.8% of vasectomies are performed in a physician’s office, 11.5% as a hospital outpatient, 5.5% at freestanding surgery 
centers, and 4.2% in other settings [105]. 
e Assuming 50% are performed postpartum and 50% as interval procedures; 96% of interval procedures are outpatient [1, 106]. 
f Assuming 83 acts of intercourse per year [1]. 
g Assuming 60% of births are mistimed and would have occurred 2 years later, a 3% discount rate is applied [1]. 
hAssuming 35% of abortions are performed in the hospital, 49% occur in abortion or other clinics, and 17% in physician offices [107]. Assumes that 23% of 
abortions are medication abortions and the remaining 77% are surgical [101].  
i Based on the DRG codes and proportion of in-hospital abortions used for induced abortion.  
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Table 5.4 Utilities for Switching and No-Switching Models 
Health State Mean 
Standard 
Deviation Source Source Population Method Notes 
Induced Abortion  0.992 0.043 
Schwarz 
2008 
N=192 non-pregnant US women, 
sexually active women who were not 
trying to get pregnant when they 
presented at three Pittsburgh clinics in 
2006 
Time 
Trade-Off 
Uses the utility estimate for 
unintended pregnancy. 
Spontaneous Abortion 0.85 0.180 
Kupperman 
2004 
N = 584 pregnant US women aged 16-47 
years recruited from 23 San Francisco 
practices 
Time 
Trade-Off 
This utility estimate is confirmed by 
the following additional sources: 
Payne 2004 (expert estimate = 0.8), 
Kaimal 2015 (estimate = 0.88, SD 
=0.178). 
Pregnancy and Birth 0.912 0.11 
Kupperman 
2004, 
Schwarz 
2008 
N = 584 pregnant US women aged 16-47 
years recruited from 23 San Francisco 
practices 
Time 
Trade-Off 
Reducing by unintended pregnancy 
disutility to reflect the fact that all 
pregnancies in this model are 
unplanned and this utility was 
derived from a mixed/positive about 
pregnancy sample 
Ectopic Pregnancy 0.982 0.13 
Smith 2008, 
Lawrence 
2001 
N = 150 US women with no history of 
pelvic inflammatory disorder who were 
older than 18 and recruited in Pittsburgh 
Time 
Trade-Off 
Reducing by unintended pregnancy 
disutility to reflect the fact that all 
pregnancies in this model are 
unplanned and this utility was 
derived from a sample positive about 
their pregnancies. Used maximum 
SD giving a feasible beta. 
Contraception 1          Assumption. 
Urinary Tract Infection 0.994 0.03 
Bermingham 
and Ashe 
2012 
N = 146 adult US women with mean age 
34 (SD 12 years) with symptomatic, 
diagnosed UTI recruited from two family 
medicine clinics 
Visual 
Analogue   
Venous 
Thromboembolism 0.982 0.009 
Hogg 2013, 
Calculation 
N = 216 patients of an Ottawa 
thrombosis clinic with a history of lower 
limb deep vein thrombosis or pulmonary 
embolism 
Standard 
Gamble 
Calculated the weighted utility 
including DVT and PE events 
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Health State Mean 
Standard 
Deviation Source Source Population Method Notes 
Highly Effective 
Methods 0.994 0.07 
Smith 2008, 
Hillis 1999 
Sterilization utilities are <1 due to 
sterilization regret. N = 150 US women 
with no history of pelvic inflammatory 
disorder who were older than 18 and 
recruited in Pittsburgh 
Time 
Trade-Off 
Using lower bound of sterilization 
regret because sample of women 
who do not want pregnancy. Used 
maximum SD giving a feasible beta. 
Induced 
Abortion  0.986 0.070 Calculation     
 
Spontaneous 
Abortion 0.844 0.250 Calculation     
 
Ectopic 
Pregnancy 0.976 0.12 Calculation     
Used maximum SD giving a feasible 
beta. 
Effective Methods 0.999 0.020 
Trussell 
2009, 
Calculation Pill utility is <1 due to adverse events.   
Population-weighted average of 
method specific utilities. Used 
maximum SD giving a feasible beta. 
Induced 
Abortion  0.991 0.063 Calculation     
 
Spontaneous 
Abortion 0.849 0.200 Calculation     
 
Ectopic 
Pregnancy 0.981 0.100 Calculation     
Used maximum SD giving a feasible 
beta. 
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Analyses 
Uncertainty Analysis 
We first conducted a probabilistic uncertainty analysis. For the probabilistic uncertainty 
analysis, we assigned probability distributions to uncertain input parameters, then ran the model 
10,000 times, drawing a new value for each input parameter from its distribution for each run 
[33]. Our probabilistic uncertainty analysis incorporated uncertainty in costs, utilities, and the 
mix of contraceptive methods for each intervention. Costs were parameterized using Gamma 
distributions, except the cost of the intervention, and utilities were parameterized with Beta 
distributions [32]. Where standard deviations were unavailable for the total cost of the method, 
the distribution was parameterized so that the range of likely values reported in the literature was 
treated as a 95% confidence interval of a normal distribution, with the base value being the 
mean, to derive a standard deviation. This was done to avoid implausible distributions but 
incorporate a realistic portrayal of uncertainty over the parameter’s range, as recommended by 
the International Society for Pharmacoeconomics and Outcomes Research-Society for Medical 
Decision Making (ISPOR-SMDM) Modeling Good Practices Task Force Working Group [108].   
Threshold Analysis 
We then conducted a threshold analysis on the costs of the interventions. To do this, we 
assumed a willingness-to-pay threshold of $0. A willingness-to-pay threshold is the amount that 
decision makers are willing to pay per QALY gained for an intervention [109]. We chose a 
willingness-to-pay threshold of $0 rather than the more typical $50,000 because the interventions 
were cost-saving and because reproductive health interventions often cannot rely on stable 
investment. Then we ran the model as described above and calculated net-benefits for each of the 
10,000 runs [33]. This process was repeated for a range of values for the cost of the intervention. 
This analysis produces a graph showing the average net monetary benefit for the two posters and 
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the status quo on the Y-axis and the cost per woman of the intervention on the X-axis. The 
results tell us the cost per woman of each poster at which the intervention is no longer cost 
saving, and can be used to suggest how much could be spent on dissemination and wraparound 
services during implementation. 
Sensitivity Analyses 
Next, we conducted a bivariate sensitivity analysis on the percentage of women who 
follow through on their changed intentions as a result of the posters using the no-switching 
model. To do this, we assigned each poster a variable representing follow-through. We defined 
follow-through as the percent of women who experience the effects of the poster. In practice, this 
means that if only 80% of people who are exposed to the poster actually change their behavior 
based on their stated intentions as a result of its message, then 80% of the women in the model 
would exhibit the contraceptive behavior associated with the poster, while the remaining 20% 
would exhibit the status quo behavior. We then conducted a bivariate sensitivity analysis on 
these follow-through percentages to determine whether differences in follow-through for the 
posters might affect their cost-effectiveness. The results of this analysis suggest how differences 
in the attractiveness or “stickiness” of the posters might impact cost-effectiveness. 
Supplemental Analyses 
We conducted a number of additional analyses that can be found in the Supplement and 
which will briefly be described here.  
First, we calculated incremental cost-effectiveness ratios (ICERs) for QALYs and 
unintended pregnancies averted. ICERs are calculated as the change in costs from usual care to 
the intervention divided by the change in outcomes; they represent the extra units of utility 
achieved per extra dollar spent on the intervention. In this study we calculated ICERs for both 
the patient-centered and CDC posters compared to the status quo, rather than using the usual 
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method for multiple comparisons, because there was no significant difference in effectiveness 
between the two interventions found in the previous study (see Chapter 4).  
Second, we calculated cost-effectiveness acceptability curves (CEAC). To do this, we run 
the model 10,000 times as described previously and calculate net-benefits for each of the 10,000 
runs using willingness-to-pay thresholds from $0-$100,000 [33]. We then graph the proportion 
of trials in which each intervention has the highest net-benefit against willingness-to-pay.  
Finally, using the method-specific models, rather than the categories of effectiveness 
models, we performed validity checks on (1) the primary data set’s generalizability to the US 
population of women who are at risk of unintended pregnancy, as well as (2) the comparability 
of results produced by the models to reality. The methods used for these validity checks, as well 
as the results, can be found in the Supplement.  
Results  
Table 5.5 shows the number of unplanned births total and per woman, QALYs per 
woman, and costs per woman for the status quo, the patient-centered poster, and the CDC poster 
over the course of the 5-year time horizon for both models. Both posters reduce costs, reduce 
unplanned pregnancies, and increase quality of life compared to the status quo.  
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Table 5.5 Results of No-Switching and Switching Models 
No-Switching Model 
Outcome Status Quo Patient-Centered 
Poster 
CDC Poster 
Total Unintended Pregnancies 7,620 5,677 5,793 
Mean Unintended Pregnancies Per Woman 0.76 (SD 0.03) 0.57 (SD 0.03) 0.58 (SD 0.03) 
Mean Costs per Woman $6,496.07 
(SD $493.69) 
$5,588.83 
(SD $487.01) 
$5,791.44 
(SD $521.83) 
Mean QALYs per Woman 4.66 (SD 0.09) 4.67 (SD 0.12) 4.67 (SD 0.13) 
ICER (compared to Status Quo)  DOMINANT DOMINANT 
Switching Model 
Total Unintended Pregnancies 5,119 3,638 3,561 
Mean Unintended Pregnancies Per Woman 0.51 (SD 0.01) 0.36 (SD 0.01) 0.36 (SD 0.01) 
Mean Costs per Woman $4,600.37  
(SD $338.61) 
$4,050.26 
(SD $392.47) 
$4,112.27 
(SD $421.85) 
Mean QALYs per Woman 4.67 (SD 0.15) 4.68 (SD 0.19) 4.68 (SD 0.20) 
ICER (compared to Status Quo)  DOMINANT DOMINANT 
N=10,000 runs for each model, cohort of n=10,000 
 
Figures 5.2 and 5.3 show the threshold analyses on the per-woman cost of the 
intervention for the no-switching and switching models, respectively. We found that for the no-
switching model, the threshold for the CDC poster was approximately $1,000 and for the patient-
centered poster it was approximately $1,150. For the switching model, the thresholds were 
approximately $740 for the both posters. This means that the threshold amount could be spent 
per woman and, on average, the intervention would still break even compared to the status quo.  
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Figure 5.2 Threshold Analysis on Cost of Intervention per Woman for No-Switching Model 
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Figure 5.3 Threshold Analysis on Cost of Intervention per Woman for Switching Model 
Figure 5.4 shows the results of the bivariate sensitivity analysis on follow-through using 
the no-switching model. The status quo is preferred at a willingness-to-pay threshold of $0 if 
follow-through for the CDC poster is <18% and follow-through for the patient-centered poster is 
<20% (the region highlighted in gold). Follow-through for the patient-centered poster must be at 
least 2% higher than the CDC poster follow-through for it to generate a higher net monetary 
benefit at a willingness-to-pay threshold of $0 (the region highlighted in red). 
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Figure 5.4 Bivariate Sensitivity Analysis of Variation in Follow-Through for Posters for 
No-Switching Model 
Discussion 
Our models show that both contraceptive effectiveness posters are dominant 
interventions- meaning they are cost saving and improve health outcomes—relative to the status 
quo. Depending on the modeling strategy, the patient-centered and CDC posters averted 1,481-
1,943 and 1,558-1,827 unintended pregnancies, respectively. Both models found that the posters 
increased the total number of QALYs per woman by 0.01. Depending on the modeling strategy, 
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total costs per woman were reduced by $550-907 by the patient-centered poster and $488-705 by 
the CDC poster. 
These results were robust in probabilistic uncertainty and bivariate sensitivity analyses. In 
particular, even if policymakers are unwilling to pay any additional money to improve outcomes, 
we found that implementing the posters could cost $740 per woman before they were no longer 
cost saving. We also found that the posters would have to change the behavior of as few as 18% 
of women to produce these cost savings. This suggests that the cost-effectiveness of these poster 
interventions is extremely robust to variations in implementation costs and effectiveness. The 
cost savings produced are more than enough to support additional time for providers to counsel 
patients on contraception or to finance an aggressive dissemination campaign. 
This work adds to the previous literature on contraceptive cost-effectiveness modeling in 
a number of ways. First, these models rarely use the standard unit of health outcomes, QALYs, 
to measure improvements in health. It is valuable to use QALYs to measure outcomes in cost-
effectiveness models because it allows policymakers to prioritize the most cost-effective 
interventions across diseases and conditions. While some studies [91, 110] have drawn on 
utilities estimated in one 2004 cost-effectiveness model [91], these utilities may not be 
generalizable to the general population because they were estimated using a convenience sample 
of female members of the research team. Other previous cost-effectiveness contraception models 
using QALYs may use more reliable sources, but incorporate such a limited number of 
reproductive health outcomes that they are unlikely to accurately estimate health benefits [111]. 
Our model synthesized the research on utility scores for commonly modeled reproductive health 
outcomes, prioritizing data that is representative of US women who use contraception. Future 
researchers can improve the policy usefulness of their contraceptive cost-effectiveness models by 
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drawing on the utilities in this model. However, our review to identify utilities also highlighted 
several areas of future research for the field. Direct estimates of utility scores for abortions and 
contraception would improve the accuracy of future cost-effectiveness studies of contraception. 
Our work also adds to the contraceptive cost-effectiveness modeling literature by creating 
two models, one simulating contraceptive switching and one not. Previous studies have chosen 
one of these strategies, making it difficult to compare results between different models. We find 
that the results of our models are comparable, with lower total costs and total unintended 
pregnancies for the switching versus the no-switching model. Future research on contraceptive-
method dependent probabilities of switching to other contraceptive methods, or on lifetime 
trajectories of contraceptive use, would improve contraceptive models that simulate 
contraceptive switching. 
However, our work has a number of limitations. The first is that contraceptive transitions 
would ideally be modeled using method-specific transition probabilities. We have addressed this 
limitation by creating both a switching and a no-switching model to address the shortcomings of 
each approach. A second limitation is that the primary data used in this model to estimate 
contraceptive choices after viewing a poster was based on contraceptive preferences rather than 
actual behavior. While intentions and preferences are predictive of behavior [86, 87], it is likely 
that the actual effectiveness of these posters will be less than estimated in the base model. 
However, our bivariate sensitivity analysis demonstrates that even dramatically reducing 
women’s likelihood of following through on their intentions as a result of these posters would 
still save costs and improve reproductive health outcomes. 
Our work has a clear implication for clinical practice. Using contraceptive effectiveness 
educational posters in health care settings would be an inexpensive intervention that does not 
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require the time of health care providers to implement. This work demonstrates that even if the 
costs to produce and implement this intervention were much higher and its effectiveness reduced 
in the path to implementation, it would still be a cost-effective choice to improve women’s 
reproductive health in the US. This work strongly suggests that either poster is preferable to no 
intervention at all.   
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CHAPTER 6: POLICY IMPLICATIONS, LIMITATIONS, AND CONCLUSIONS 
Summary of Findings, Policy Implications, and Limitations 
This study used three different methods—cognitive interviews, a randomized control 
trial, and cost-effectiveness modeling—to develop and evaluate the cost-effectiveness of a 
patient-centered poster designed to educate women about contraceptive effectiveness. 
Throughout the study we compared this poster to the CDC’s current contraceptive effectiveness 
poster, performing a parallel evaluation in the process. This study is the first attempt to evaluate 
the CDC’s poster, and is the first that we have identified that describes the design and evaluation 
of a reproductive health poster intended to be used without the guidance of a health care 
provider. Previous studies have examined the impact of charts on contraceptive knowledge [7, 
83], but not complete posters, and have tested contraceptive knowledge using unvalidated 
instruments. No previous study that we have identified has examined the cost-effectiveness of an 
educational intervention on contraceptive behavior.  
In Chapter 3, our objective was to refine the patient-centered poster and qualitatively test 
the comprehension, relevance, acceptability, design, and preference of the patient-centered poster 
compared to the CDC poster. By the conclusion of the study we found that the majority of 
women found the final version of the patient-centered poster to be more comprehensible and 
relevant than the CDC poster, and the majority also preferred the design of the patient-centered 
poster. The majority of women preferred the final version of the poster overall and few 
acceptability concerns were raised with it.  
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In Chapter 4, we examined whether the patient-centered poster or the CDC poster was 
more effective at improving women’s contraceptive knowledge, the accuracy of their perceived 
pregnancy risk, and the effectiveness of the methods of contraception they were most likely to 
use in the following year. We found that both posters improved contraceptive knowledge 
significantly compared to baseline, with a 3.6 percentage point improvement for the CDC poster 
and a 6.4 percentage point improvement for the patient-centered poster (p<0.0001). We also 
found that exposure to the patient-centered poster resulted in significant improvements in 
contraceptive knowledge compared to the CDC poster (p<0.0001). Finally, we found that both 
posters led to a significant 3 percentage point improvement in the effectiveness of the 
contraceptive methods that women were most likely to use in the following year compared to 
baseline (p<0.01 for patient-centered and p<0.001 for CDC). These results are clinically 
significant given that they appeared after women were passively exposed to a poster for only a 
minute, suggesting that this intervention would require health care providers to invest little of 
their valuable time or resources to see effects. 
In Chapter 5, we asked whether the CDC and patient-centered posters were more cost-
effective than the status quo at preventing unintended pregnancies using a private payer’s 
perspective. In two models, one of which simulated contraceptive switching and discontinuation 
and the other of which did not, we found that both posters reduced costs and improved health 
outcomes relative to the status quo. These results held in probabilistic sensitivity analyses of both 
models and a bivariate sensitivity analysis testing extreme values of the effectiveness and cost 
per woman of the interventions. This suggests that the posters would likely be cost-effective 
even if the implementation process led to reduced impact on contraceptive choices and the costs 
of using the posters were quite high.   
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This study makes a number of contributions to the literature. First, it demonstrates that 
educational posters on reproductive health are cost-effective interventions for improving 
contraceptive knowledge and intentions, which have been linked to improved contraceptive use 
[23, 86, 87, 114-116]. This is valuable because while many reproductive health posters may exist 
and be in use, none have previously been evaluated. Our study shows that not all posters are 
equally effective at improving contraceptive knowledge, and it suggests that further evaluations 
of other posters may identify more or less effective strategies of communicating reproductive 
health information.  
Second, this study demonstrates that women’s feedback on these posters can highlight 
comprehension, relevance, and acceptability issues that researchers alone may not identify. 
Women’s health researchers, being well-educated, knowledgeable about reproductive health, and 
numerate, may not be able to identify when they are using specialized technical language or 
approaches to risk communication that do not suit a less health literate audience. They are also 
likely to have different priorities for contraception than the average user, since they are likely to 
have delayed childbearing to complete an advanced education. This affects the types and formats 
of information that they are likely to include in an educational poster. Women from the target 
population for educational materials should and can be involved in the design process, as 
recommended by CDC and OPA [9].  
Third and finally, this is one of the first studies to use the Contraceptive Knowledge 
Assessment, a validated instrument for measuring women’s contraceptive knowledge [30]. 
Previously, the only contraceptive knowledge assessment (the Contraceptive Knowledge 
Inventory) that had been validated was created in 1976 and had a number of questions on 
methods that were out of date or are rarely used now, such as douching, cervical caps, and the 
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Lippes Loop [117]. Our study demonstrates that the Contraceptive Knowledge Assessment is 
responsive, meaning that when individuals are tested with the instrument, provided with 
information that should change their responses, and then re-tested, their responses do in fact 
change. Our study also gathered baseline contraceptive knowledge using the Contraceptive 
Knowledge Assessment in a much larger and more diverse population than it has ever previously 
been used in. Our baseline data can act as a reference point for future studies interested in 
knowing how their results might differ from a population that is generalizable to the US female 
internet-using population aged 18-44.   
This dissertation has several limitations, of which the largest are highlighted here. First, 
we were only able to gather contraceptive preferences and intentions in the randomized control 
trial testing the posters. While intentions are predictive of future contraceptive behavior [86, 87, 
116], there are differences. These differences would reduce the generalizability of the results of 
Aims 2 and 3 to women’s real-world behavior. Second, in Aim 1 we only interviewed North 
Carolina women from the Research Triangle area. While we were able to recruit a relatively 
diverse sample, further interviews with women from around the nation would likely produce 
additional problems with the acceptability of both posters. Third, in Aim 3 we were not able to 
use contraceptive-method-specific transition probabilities in the model that simulated 
contraceptive switching and discontinuation. This resulted in a model that did not produce good 
approximations of observed contraceptive use in the population. 
Despite these limitations, this study is a policy-relevant contribution to the literature on 
unplanned pregnancy prevention interventions. It provides a window into the development, 
refinement, and evaluation of an intervention that could relatively easily be implemented across 
the country to reduce unplanned pregnancies.  
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Future Research Agenda 
The most pressing future research needed is testing whether the posters significantly 
change actual contraceptive behavior in the clinical setting. Actual contraceptive behavior could 
be measured in a variety of ways: contraceptive choices made at clinical visits, continuation of 
use of those contraceptives at later follow-up visits, consistency of use of contraceptive methods 
that require regular maintenance, and/or accuracy of use for methods that require correct use to 
be effective. Furthermore, clinical implementation of these posters could be accomplished in a 
variety of ways. They could be combined with counseling from providers (nurses, community 
health workers, clinicians), as in previous health education studies [56]. They could also be 
combined with computerized decision aids for contraceptive selection, an area of growing 
interest and research [56, 118, 119]. Because of the large cost savings produced by the posters, 
they could be paired with significant wraparound services to increase their effectiveness and 
likely remain cost-effective. 
 Using the data we collected, we could also look health and cost barriers to using certain 
contraceptive methods. For example, new insurance rules regarding contraception that were 
passed as part of the Affordable Care Act should have made contraception accessible financially 
to practically all women with private insurance. However, we still saw that 19% of our study 
sample reported being unable to use some contraceptive methods due to the costs, despite only 
10% of the sample being uninsured. Furthermore, 16% of the sample reported being unable to 
use some contraceptive methods for health reasons. Patterns in these reported health barriers to 
contraceptive use could illuminate the need for education in this area so that women know the 
full range of contraceptive methods that are available to them.  
There is also the need for future research to improve future contraceptive cost-
effectiveness modeling projects. First, secondary data analyses should be performed to identify 
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contraceptive-method specific transition probabilities that can be used in more accurate future 
models of contraceptive behavior. Second, preference studies should be conducted to estimate 
utilities for important reproductive health states like abortions, miscarriages, and the use of 
different contraceptive methods. 
This dissertation also collected data that could be used to psychometrically evaluate the 
Contraceptive Knowledge Assessment. The previous validation of the Contraceptive Knowledge 
Assessment was done in a small sample, which prevented the authors from estimating the 
predictive ability of individual questions relative to the larger instrument. This type of analysis 
can be used to assess the overall quality of an instrument and reduce the length of an instrument. 
This work would be useful to any reproductive health researcher interested in measuring 
contraceptive knowledge. 
Finally, other posters that are currently being used to educate women about reproductive 
health should be evaluated in the same way that the patient-centered and CDC posters were 
evaluated in this study. There is no comprehensive catalogue of the posters that are in use, and 
the posters available online are constantly changing. To ensure that women are getting the best 
possible educational outreach, these posters should be designed and tested thoughtfully.  
Conclusions 
This dissertation strongly suggests that the patient-centered poster should begin to be 
tested in the clinical setting because it is a promising intervention for increasing contraceptive 
knowledge and reducing risk factors for unplanned pregnancy. In Chapter 3 we demonstrated 
that the patient-centered poster is preferred by women overall and would generate have few 
acceptability concerns. In Chapter 4 we showed that the patient-centered poster has a significant 
impact on contraceptive knowledge and the effectiveness of contraceptive methods that women 
are most likely to use, both important predictors of contraceptive behavior. In Chapter 5 we 
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demonstrated that the patient-centered poster is projected to save costs and improve health 
outcomes when using a private payer perspective. These findings will be help the CDC in its 
planned revision of their contraceptive effectiveness poster, and should help clinicians and public 
health specialists when they select how to allocate their limited time, effort, and resources 
towards interventions to reduce unplanned pregnancies.  
  90 
APPENDIX A: SUPPLEMENTAL MATERIAL FOR CHAPTER 5 
Additional Material for Models Using Categories of Effectiveness 
Figures A.1-A.4 show additional results for the models using contraceptive categories 
rather than individual contraceptive methods. Figures A.1 and A.2 are the cost-effectiveness 
acceptability curves for the no-switching and switching models, respectively. In both models the 
patient-centered poster is preferred to the CDC poster in over half of the model runs. The no-
switching model shows an increased preference for the patient-centered poster over the CDC 
poster over a wider range of willingness-to-pay values. 
 
Figure A.1 CEAC for No-Switching Model with Categories 
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Figure A.2 CEAC for Switching Model with Categories 
Figures A.3 and A.4 show the ICER planes for the no-switching and switching models, 
respectively. In both models the results for the CDC and patient-centered posters have a great 
deal of overlap, indicating that there is little difference in costs and effectiveness between the 
two posters. The results are also tightly clustered along the maximum possible QALY result, 
suggesting that in general the increase in QALYs for the posters is small. 
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Figure A.3 Incremental Cost-Effectiveness Ratio Plane for No-Switching Model 
 
Figure A.4 Incremental Cost-Effectiveness Ratio Plane for Switching Model 
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Material Describing Models Using Individual Contraceptive Methods 
Model Structure 
Figure A.5 illustrates the structure of the models. Two Markov models were constructed 
in TreeAge Pro Healthcare (TreeAge Software, Williamstown, MA). Both use a 5-year time 
horizon and a Markov cycle length of 1 year. We chose a 5-year time horizon based on previous 
studies showing that longer-acting contraceptive methods have high up-front costs but also many 
benefits that accrue over the course of several years [1, 90]. The model structure was the same 
for all branches, but is only shown completely for one branch for the sake of brevity. A square 
decision node indicates that the entire hypothetical cohort travels down each of these branches. A 
circular chance node indicates that when women reach this node, they have a certain probability 
of entering each of the states branching off of the node, and these probabilities sum to one. In 
this model, some chance nodes are also cyclical Markov nodes. This means that when a woman 
reaches this node, she records the outcome labeled at the node and then is put back into the 
model at the node of the same color to the left in the tree. 
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Legend: Dashed line is only present in the switching model.  
Figure A.5 Structure of Contraceptive Education Poster Markov Model 
After being exposed to one of the alternatives (CDC poster, patient-centered poster, or 
status quo), women can choose to use one of twelve contraceptive methods or no method. After 
women choose a contraceptive method, there are five subsequent potential fertility states: no 
contraceptive failure, ectopic pregnancy, miscarriage, induced abortion, and unintended birth. In 
the model that does not simulate contraceptive switching or discontinuation, women resume 
using their method after experiencing one of these five outcomes. This approach has been used in 
several previous contraceptive cost-effectiveness models [1, 90, 92].  
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In the model that simulates contraceptive switching and discontinuation, after 
experiencing one of the five fertility states, women can choose to discontinue their method and 
switch to a new one. The likelihood of discontinuation is method-specific. The likelihood of 
switching to each method is the same as the probability of choosing that method initially, with 
the probability of choosing the discontinued method removed and evenly divided between the 
remaining methods. Only one previous model allowed women to switch methods, and this model 
assumed that they switched to an “average” contraceptive method [93]. We chose to create two 
models, one modeling switching and the other not modeling switching, to understand whether 
there are differences in estimates of costs and benefits between the two and to increase the 
comparability of our results to previous cost-effectiveness models. 
In summary, women in these models experience an annual cycle of being exposed to a 
poster (or no poster in the status quo), choosing a contraceptive method, experiencing a fertility 
state, and (in the switching model only) either switching to a new contraceptive method or 
continuing with the same method.  
Key Model Assumptions 
m. The models apply to reproductive-age women (18-44) who do not intend to conceive.  
n. All women were assumed to be candidates for all contraceptive methods. 
o. Women could only use one contraceptive method at a time.  
p. We assumed perfect implementation of the posters. In other words, every time a woman 
chose a contraceptive method she would be exposed to the poster and would choose a 
contraceptive method with the probabilities associated with that poster. 
q. Contraceptive failures other than unintended births and method discontinuations were 
assumed to occur at the midpoint of the cycle [1, 90]. 
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r. Individuals who choose to contracept using tubal ligation or a partner’s vasectomy did 
not discontinue their method [90].  
s. Couples were assumed to have 83 acts of intercourse per year [1]. 
t. Women could only conceive once per year.  
u. We assumed that 60% of unintended births were mistimed rather than unwanted and 
would have occurred 2 years later [50]. Because of this we discounted the costs and 
benefits associated with mistimed births. 
v. We assumed contraceptive method failure occur at rates corresponding to typical use. 
Typical use failure rates included failures due to incorrect or inconsistent use by 
contraceptive users.  
w. We assumed that failure rates are constant over time.  
x. A discount rate of 3% was used for all costs and quality-adjusted life years incurred after 
1 year. 
Input Parameters  
We used parameters estimates derived from a literature review. This literature review was 
not systematic, but prioritized results that came from: 1) high-quality studies, 2) using US data, 
3) studying women of reproductive age, and 4) with recent data. Table A.1 has probabilities for 
continuing to use each contraceptive method after one year. We use primary data to estimate the 
mix of methods used if all women were counseled using the new poster or the CDC poster (see 
Table A.1). The primary data was from a randomized control trial studying a sample of sexually 
active, female Amazon Mechanical Turk users aged 18-44 who were not pregnant or intending to 
conceive. The expected mix of methods was the percentage of this sample ranking each method 
as the most likely method they would switch to were they to switch methods in the next year, 
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excluding their current method. For the status quo, we applied this definition to the baseline data. 
These counts were used to parameterize a Dirichlet distribution [94].  
Table A.2 shows probabilities of method failures and adverse events.   
  
9
8
 
Table A.1 Input Probabilities for Contraceptive Methods 
Method 
Methods 
Failures 
After One 
Yeara 
Percent 
Continuing Use 
After One Yearb 
Pre-
Intervention 
Number Using 
(N=902) (%) 
Post-Patient-
Centered Poster 
Number Using 
(N=902) (%) 
Post-CDC-
Poster Number 
Using (N=902) 
(%) 
Observed 
Proportions 
in Populationc 
No Method 85% 15% 57 (6%) 35 (4%) 47 (5%) 10% 
Pill 9% 68% 116 (13%) 112 (12%) 112 (12%) 23% 
Male Condom 18% 53% 196 (22%) 154 (17%) 140 (16%) 14% 
Withdrawal 22% 43% 141 (16%) 91 (10%) 79 (9%) 4% 
Male Sterilization 0.15% 100% 80 (9%) 102 (11%) 104 (12%) 7% 
Female Sterilization 0.5% 100% 37 (4%) 53 (6%) 35 (4%) 23% 
IUD/IUSd 0.2% 80% 68 (8%) 112 (12%) 144 (16%) 7% 
Injection 6% 56% 34 (4%) 50 (6%) 34 (4%) 4% 
Patch 9% 68% 25 (3%) 37 (4%) 37 (4%) 1% 
Ring 9% 68% 31 (3%) 29 (3%) 23 (3%) 2% 
Implant 0.05% 84% 45 (5%) 71 (8%) 97 (11%) 1% 
Fertility Tracking 24% 51% 66 (7%) 50 (6%) 48 (5%) 1% 
Other Methodsc 19% 50% 6 (1%) 6 (1%) 2 (0%) 1% 
Spermicides 28% 0.42    .06% 
Sponge (Parous) 24% 0.57    .06% 
Sponge (Nulliparous) 12% 0.46    .06% 
Diaphragm 12% 0.57    .06% 
Female Condom 21% 0.49    .06% 
a Source: [17] 
b Source: [95] 
c Source: [96]. Assumes that “other” contraceptive method use is equally split between diaphragm, female condoms, spermicide, and sponge. 
Averages the continuation and failure rates of “other” methods to find joint continuation and failure rates. 
d Uses hormonal IUS continuation and failure rates [97]. 
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Table A.2 Input Probabilities for Method Failures and Adverse Events [1] 
Method 
Ectopic 
Pregnancy 
Induced 
Abortion 
Spontaneous 
Abortion Birth Amenorrhea 
Venous 
Thrombo-
embolism 
Urinary 
Tract 
Infections 
Postoperative 
Complications 
No Method 0.01 0.4554 0.1683 0.3663     
Spermicides 0.01 0.4554 0.1683 0.3663   0.31  
Withdrawal 0.01 0.4554 0.1683 0.3663     
Fertility Awareness 
Methods 0.01 0.4554 0.1683 0.3663     
Sponge 0.01 0.4554 0.1683 0.3663     
Diaphragm 0.01 0.4554 0.1683 0.3663   0.31  
Male Condom 0.01 0.4554 0.1683 0.3663     
Female Condom 0.01 0.4554 0.1683 0.3663     
Pill 0.01 0.4554 0.1683 0.3663 0.03 0.00005 0.15  
Patch 0.01 0.4554 0.1683 0.3663 0.001 0.00005   
Ring 0.01 0.4554 0.1683 0.3663 0.03 0.00005   
Injection 0.01 0.4554 0.1683 0.3663 0.4    
IUS/IUDa 0.5 0.23 0.085 0.185 0.2    
Implant 0.01 0.4554 0.1683 0.3663 0.222    
Female Sterilization 0.33 0.3082 0.1139 0.2479    0.012 
Male Sterilization 0.01 0.4554 0.1683 0.3663    0.00043 
a Uses hormonal IUS rates [97]. 
  
  100 
Costs 
Costs for private payers associated with contraception included those for the 
contraceptive method itself, physician services, method failures, and adverse events [1] (Table 
A.3). The costs of adverse events were weighted by their likelihood and incorporated into the 
total cost of each method. Direct non-medical costs and indirect costs are not included in the 
model. All costs were adjusted to 2017 US dollars using the medical care services or physician 
services component of the Consumer Price Index as appropriate [99]. In the base model we 
assume that the costs associated with producing and implementing the posters are negligible.  
Utilities 
Utilities are measured using quality-adjusted life years (QALYs) and the natural unit 
outcome of the number of unintended pregnancies averted. QALYs are a commonly used 
outcome measure in comparative effectiveness research that incorporates morbidity and 
mortality into a single measure [32]. A QALY is an abstract concept representing one year of life 
in perfect health. To calculate QALYs, we have to associate each event with a utility, which is a 
score reflecting an individual’s preference for a health state [32]. These scores range from zero – 
representing death – to 1 – representing perfect health [32]. We sourced utilities from our 
literature review (Table A.4).  
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Table A.3 Cost Inputs for the Models 
Treatment or Outcome and Code Annual 
Cost 
Model 
Cost 
Distribution Notes Source Source 
Year 
CONTRACEPTIVE METHODS 
IUD       
Average IUD/IUS Cost a $976.24 $829.81  Range: $698.07 – $927.15 
Standard Deviation: $89.07 
[112] 2017 
IUD Insertion (CPT 58300) $150 $165.21  Range: $72.42-$330.42 [92] 
[103] 
2015 
2011 
IUD Removal (CPT 58301) $235 $258.83  Range: $187.24 - $330.42 [103] 2011 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Total First Year Costb  $1,388.66 Gamma Raw Range: $1,047.09 – 
$1,984.50 
Mean: $1,388.66 
Shapec: 33.72 
Scalec: 41.18 
  
Implant       
Nexplanon® a $1017.48 $864.86   [112] 2017 
Cost of Insertion (CPT 11975) $143 $145.87   [92] 2015 
Cost for Removal (CPT 11976) $146.08 $180.15  Upper Bound: $404.63 [92] 
[103] 
2015 
2011 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Total First Year Costb  $1,323.66 Gamma Raw Range: $1,281.87 – 
$1,819.13  
Mean: $1,323.66 
Shapec: 93.27 
Scalec: 14.19 
  
Injectable Contraceptive       
Depo Provera® a $915.56 $778.23   [112] 2017 
Injection (CPT 90782) (three times 
per year) 
$64.89 $80.03   [1]  2007 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
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Treatment or Outcome and Code Annual 
Cost 
Model 
Cost 
Distribution Notes Source Source 
Year 
Total Annual Costb  $1,009.19 Gamma Raw Range: $962.50 - 
$1,320.84 
Mean: $1,009.19 
Shapec: 121.88 
Scalec: 8.28 
  
Vasectomy       
Procedure cost d $707.97 $938.97  Range: $409.38 – $1,169.52 
 
[1] 
[103] 
2007 
2011 
Total First Year Costb  $939.05 Gamma Raw Range: $409.38 – 
$1,169.52 
Mean: $939.05 
Shapec: 23.45 
Scalec: 40.04 
  
Tubal Ligation       
Procedure cost e $2,833.79 $3,758.41  Range: $1,754.16-$7,016.66 [1] 
[103] 
2007 
2011 
Total First Year Costb  $3,841.33 Gamma Raw Range: $1,837.08 - 
$7,099.58 
Mean: $3,841.33 
Shapec: 8.19 
Scalec: 469.17 
  
Oral Contraceptive       
Average Birth Control Pill a $946.05 $804.14  Range: $280.36-$2,305.06 
Standard Deviation: $610.75 
[112] 2017 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Total Annual Costb  $936.36 Gamma Raw Range: $375.83 - 
$2,665.37 
Mean: $936.36 
Shapec: 2.57 
Scalec: 364.32 
  
Transdermal Patch       
Xulane® a $577.32 $490.72   [112] 2017 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 2015 
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Treatment or Outcome and Code Annual 
Cost 
Model 
Cost 
Distribution Notes Source Source 
Year 
[103] 2011 
Total Annual Costb  $601.75 Gamma Raw Range: $566.03 - $823.44 
Mean: $601.75 
Shapec: 83.97 
Scalec: 7.17 
  
Vaginal Ring       
NuvaRing® a $2,230.44 $1,895.87   [112] 2017 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Total Annual Costb  $2,010.09 Gamma Raw Range: $1,973.34 – 
$2,238.18 
Mean: $2,010.09 
Shapec: 885.23 
Scalec: 2.27 
  
Male Condom       
Retail – Male Condom f $1 $83.87 Gamma Raw Range: 12.58 ($0.15 per 
condom) – $654.18 ($7.80 per 
condom) 
Mean: $83.87 
Shapec: 0.26 
Scalec: 319.41 
[113] 2016 
Fertility Awareness Methods 0 0     
Withdrawal 0 0     
No Method 0 0     
Other Methods       
Female Condom       
FC Female Condom f $2 $167.64  Raw Range: $109.03 ($1.30 
per condom) – $293.54 ($3.50 
per condom) 
[113] 2016 
Diaphragm       
Caya Contoured Diaphragm® a $90 $76.50   [112] 2017 
Gynol II f $9.28 $42.79  Range: $37.74 ($0.45 per use) 
– $234.83 ($2.80 per use) 
[112] 
[113] 
2017 
2017 
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Treatment or Outcome and Code Annual 
Cost 
Model 
Cost 
Distribution Notes Source Source 
Year 
 
Diaphragm Fitting (CPT 57170) $91.12 $120.85  Range: $116.94-$233.89 [1] 
[103] 
2007 
2011 
Office Visit (CPT 99212) $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Total First Yearb  $387.48  Raw Range: $342.84 - $912.84   
Total Subsequent Yearsb  $79.99  Raw Range: $74.94 - $272.03   
Spermicides       
Gynol II f $9.28 $42.79  Range: $37.74 ($0.45 per use) 
– 234.83 ($2.80 per use) 
[112] 
[113] 
 
2017 
2017 
Total Cost Annuallyb  $79.99  Raw Range: $74.54 - $269.59   
Sponge       
Today Sponge f $415 $419.34  Raw Range: $293.54 ($3.50 
per sponge) – $545.15 ($6.50 
per sponge) 
[113] 2016 
Other Methods Average Total Cost 
First Year 
 $263.64 Gamma Raw Range: $138.01-$505.28 
Mean: $263.64 
Shapec: 11.84 
Scalec: 22.26 
  
Other Methods Average Total Cost 
Subsequent Years 
 $186.76 Gamma Raw Range: $138.01-$345.08 
Mean: $186.76 
Shapec: 12.5 
Scalec: 14.94 
  
HEALTH OUTCOMES 
Birthg $17,958 $18,885.14 Gamma Raw Range: $16,996.41 - 
$20,773.86 
Mean: $18,885.14 
Shapec: 384.07 
Scalec: 49.17 
[100] 2015 
Induced Abortionh $535.45 $626.18 Gamma Raw Range: $186.18 – 
$2,319.14 
Mean: $626.18 
Shapec: 1.32 
[101] 2011 
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Treatment or Outcome and Code Annual 
Cost 
Model 
Cost 
Distribution Notes Source Source 
Year 
Scalec: 472.82 
Spontaneous Abortioni $535.45 $626.18 Gamma Raw Range: $186.18 – 
$2,319.14 
Mean: $626.18 
Shapec: 1.32 
Scalec: 472.82 
[101] 2011 
Ectopic Pregnancy (DRG 378)j $10,613 $14,075.85 Gamma Range: ±10% 
Mean: $14,075.85 
Shapec: 384.16 
Scalec: 36.64 
[1] 
[92] 
2005 
2015 
ADVERSE EVENTS 
Urinary Tract Infection $97.29 $119.98   [1] 2007 
Venous Thromboembolism $10,291 $15,472.71  Upper Range: $26,183 [102] 2004 
Amenorrhea $100 $110.14  Range: $74.46- $330.42 [92] 
[103] 
2015 
2011 
Postoperative Complications - 
Vasectomy 
$144      
Postoperative Complications – Tubal 
Sterilization 
$5210      
a Costs are reported as average wholesale price (AWP). In the model, cost inputs are AWP-15% [1].  
b Costs are weighted by the likelihood of an adverse event occurring. 
c Assumes raw range is a 95% confidence interval around stated mean to derive standard deviation. 
d Trussell, Lalla, et al assume that 0.2% of vasectomies are performed inpatient, 77.1% in a physician’s office, and 22.7% as hospital outpatient [1, 104]. An updated source found 
that in 2001, 78.8% of vasectomies are performed in a physician’s office, 11.5% as a hospital outpatient, 5.5% at freestanding surgery centers, and 4.2% in other settings [105]. 
e Assuming 50% are performed postpartum and 50% as interval procedures; 96% of interval procedures are outpatient [1, 106]. 
f Assuming 83 acts of intercourse per year [1]. 
g Assuming 60% of births are mistimed and would have occurred 2 years later, a 3% discount rate is applied [1]. 
hAssuming 35% of abortions are performed in the hospital, 49% occur in abortion or other clinics, and 17% in physician offices [107]. Assumes that 23% of abortions are 
medication abortions and the remaining 77% are surgical [101].  
i Based on the DRG codes and proportion of in-hospital abortions used for induced abortion.  
j Costs of ectopic pregnancy are based on the Medical Expenditure Panel Survey from 2004 and HCUP from 2005 [1]. 
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Table A.4 Utilities for Switching and No-Switching Models 
Health State Mean 
Standard 
Deviation Source Source Population Method Notes 
Induced Abortion  0.992 0.043 
Schwarz 
2008 
N=192 non-pregnant US women, 
sexually active women who were not 
trying to get pregnant when they 
presented at three Pittsburgh clinics in 
2006 
Time 
Trade-Off 
Uses the utility estimate for 
unintended pregnancy. 
Spontaneous Abortion 0.85 0.180 
Kupperman 
2004 
N = 584 pregnant US women aged 16-
47 years recruited from 23 San 
Francisco practices 
Time 
Trade-Off 
This utility estimate is confirmed 
by the following additional sources: 
Payne 2004 (expert estimate = 0.8), 
Kaimal 2015 (estimate = 0.88, SD 
=0.178). 
Pregnancy and Birth 0.912 0.11 
Kupperman 
2004, 
Schwarz 
2008 
N = 584 pregnant US women aged 16-
47 years recruited from 23 San 
Francisco practices 
Time 
Trade-Off 
Reducing by unintended pregnancy 
disutility to reflect the fact that all 
pregnancies in this model are 
unplanned and this utility was 
derived from a mixed/positive 
about pregnancy sample 
Ectopic Pregnancy 0.982 0.13 
Smith 2008, 
Lawrence 
2001 
N = 150 US women with no history of 
pelvic inflammatory disorder who 
were older than 18 and recruited in 
Pittsburgh 
Time 
Trade-Off 
Reducing by unintended pregnancy 
disutility to reflect the fact that all 
pregnancies in this model are 
unplanned and this utility was 
derived from a sample positive 
about their pregnancies. Used 
maximum SD giving a feasible 
beta. 
Contraception 1          Assumption. 
Urinary Tract Infection 0.994 0.03 
Bermingham 
and Ashe 
2012 
N = 146 adult US women with mean 
age 34 (SD 12 years) with 
symptomatic, diagnosed UTI recruited 
from two family medicine clinics 
Visual 
Analogue   
Venous 
Thromboembolism 0.982 0.009 
Hogg 2013, 
Calculation 
N = 216 patients of an Ottawa 
thrombosis clinic with a history of 
lower limb deep vein thrombosis or 
pulmonary embolism 
Standard 
Gamble 
Calculated the weighted utility 
including DVT and PE events 
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Health State Mean 
Standard 
Deviation Source Source Population Method Notes 
Vasectomy 0.994 0.07 
Smith 2008, 
Hillis 1999 
N = 150 US women with no history of 
pelvic inflammatory disorder who 
were older than 18 and recruited in 
Pittsburgh 
Time 
Trade-Off 
Using lower bound of regret 
because sample of women who do 
not want pregnancy. Used 
maximum SD giving a feasible 
beta. 
Induced 
Abortion  0.986 0.070 Calculation     
Utility is decremented by 
vasectomy decrement and SD is 
sum of both. 
Spontaneous 
Abortion 0.844 0.250 Calculation     
Utility is decremented by 
vasectomy decrement and SD is 
sum of both. 
Ectopic 
Pregnancy 0.976 0.12 Calculation     
Utility is decremented by 
vasectomy decrement and SD is 
sum of both. Used maximum SD 
giving a feasible beta. 
Tubal Ligation 0.991 0.09 
Smith 2008, 
Hillis 1999 
N = 150 US women with no history of 
pelvic inflammatory disorder who 
were older than 18 and recruited in 
Pittsburgh 
Time 
Trade-Off 
Using lower bound of regret 
because this is a sample of women 
who don't want pregnancy. Used 
maximum SD giving a feasible 
beta. 
Induced 
Abortion  0.983 0.125 Calculation     
Utility is decremented by 
sterilization decrement and SD is 
sum of both. Used maximum SD 
giving a feasible beta. 
Spontaneous 
Abortion 0.841 0.270 Calculation     
Utility is decremented by 
sterilization decrement and SD is 
sum of both. 
Ectopic 
Pregnancy 0.973 0.13 Calculation     
Utility is decremented by 
sterilization decrement and SD is 
sum of both. Used maximum SD 
giving a feasible beta. 
Patch 1.000   
Trussell 
2009, 
Calculation 
Utility for venous 
thromboembolism*Probability of 
venous thromboembolism+1*(1-
Probability of venous 
thromboembolism)   
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Health State Mean 
Standard 
Deviation Source Source Population Method Notes 
Pill 0.999 0.020 
Trussell 
2009, 
Calculation 
Utility for VT*Probability of 
VT+Utility for UTI*Probability of 
UTI+1*(1-probability of VT-
probability of UTI)   
Used maximum SD giving a 
feasible beta. 
Induced 
Abortion  0.991 0.063 Calculation     
Utility is decremented by pill 
decrement and SD is sum of both. 
Spontaneous 
Abortion 0.849 0.200 Calculation     
Utility is decremented by pill 
decrement and SD is sum of both. 
Ectopic 
Pregnancy 0.981 0.100 Calculation     
Utility is decremented by pill 
decrement and SD is sum of both. 
Used maximum SD giving a 
feasible beta. 
Ring 1.000   
Trussell 
2009, 
Calculation 
Utility for venous 
thromboembolism*Probability of 
venous thromboembolism+1*(1-
Probability of venous 
thromboembolism)   
 
Other Method 0.999 0.03 
Trussell 
2009, 
Calculation 
Average of (probability of UTI*utility 
of UTI) for “other” methods: 
spermicide, sponge, female condom, 
and diaphragm.    
 Induced 
Abortion  0.991 0.073 Calculation     
Utility is decremented by “other” 
decrement and SD is sum of both. 
Spontaneous 
Abortion 0.849 0.210 Calculation     
Utility is decremented by “other” 
decrement and SD is sum of both. 
Ectopic 
Pregnancy 0.981 0.1 Calculation     
Utility is decremented by “other” 
decrement and SD is sum of both. 
Used maximum SD giving a 
feasible beta. 
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Analyses 
Main Analysis 
We calculated incremental cost-effectiveness ratios (ICERs) for QALYs and unintended 
pregnancies averted. ICERs are calculated as the change in costs from usual care to the 
intervention divided by the change in outcomes; they represent the extra units of utility achieved 
per extra dollar spent on the intervention. In this study we calculated ICERs for both the patient-
centered and CDC posters compared to the status quo, rather than using the usual method for 
multiple comparisons, because there was no difference in effectiveness between the two 
interventions.   
We also calculated a cost-effectiveness acceptability curve (CEAC). To do this, we first 
assign a probability distribution to uncertain input parameters and then run the model 10,000 
times, drawing a value for each input parameter from its distribution [33]. To create the cost-
effectiveness acceptability curve, we calculated net-benefits for each of the 10,000 runs using 
willingness-to-pay thresholds from $0-$100,000 [33]. A willingness-to-pay threshold is the 
amount that decision makers are willing to pay per QALY gained for an intervention, and 
$50,000 is the willingness-to-pay threshold typically used in US cost-effectiveness literature 
[109].  
Sensitivity Analyses 
We conducted a bivariate sensitivity analysis on the cost of implementing the poster 
interventions and their effectiveness using the no-switching model. To do this, we selected a 
small number of possible values for the costs of implementing the poster interventions per 
woman: $0, $10, and $100 per woman. We also selected a small range of multipliers on the 
effectiveness of the intervention: 0.1X, 0.5X, 1X, 1.5X, and 2X. Then we created a CEAC for 
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each combination of these two variables. This bivariate sensitivity analysis explores how the 
transition to implementing the posters in reality might affect their cost-effectiveness. 
We also conducted a probabilistic sensitivity analysis. Probabilistic sensitivity analyses 
use the same first steps as the cost-effectiveness acceptability curve [33]: assigning probability 
distributions to uncertain input parameters, then running the model many times while drawing a 
value for each input parameter from its distribution. Then, for each of the 10,000 runs we 
calculated the ICERs and graph their incremental utility (x) and incremental costs (y). The 
resulting graph shows the distribution of possible outcomes taking into account the uncertainty in 
our input parameters. Our probabilistic sensitivity analysis incorporated uncertainty in costs, 
utilities, and the mix of contraceptive methods for each intervention. Costs were parameterized 
using Gamma distributions and utilities were parameterized with Beta distributions [32]. Where 
standard deviations were unavailable for the total cost of the method, the distribution was 
parameterized so that the range of likely values reported in the literature was treated as a 95% 
confidence interval of a normal distribution, with the base value being the mean, in order to 
derive a standard deviation. This was done to avoid implausible distributions but incorporate a 
realistic portrayal of uncertainty over the parameter’s range, as recommended by the 
International Society for Pharmacoeconomics and Outcomes Research-Society for Medical 
Decision Making (ISPOR-SMDM) Modeling Good Practices Task Force Working Group [108].   
Validity  
We performed validity checks on (1) the primary data set’s generalizability to the US 
population of women who are at risk of unintended pregnancy, as well as (2) the comparability 
of results produced by the models to reality.  
We tested these two different aspects of external validity by using two different data sets 
to parameterize the initial mix of methods. To check (1) whether our primary data set is 
  111 
generalizable to the US population of women who are at risk of unintended pregnancy, we first 
used the primary data described in section 2.3. To check (2) whether the model’s structure and 
assumptions produce results that reflect reality, we used a nationally representative National 
Survey of Family Growth (NSFG) data on the proportion of US women aged 15-44 who are at 
risk of unintended pregnancy using each method in 2011-2013. We then identified the 
proportions of women using each contraceptive method in the status quo alternative at the end of 
the model time horizon. We compared these proportions to the proportions using each 
contraceptive method in the nationally representative NSFG data.  
Results for Models Using Individual Contraceptive Methods 
Table A.5 shows the number of unplanned births total and per woman, QALYs per 
woman, and costs per woman for the status quo, the patient-centered poster, and the CDC poster 
over the course of the 5-year time horizon for both models. Both posters reduce costs, reduce 
unplanned pregnancies, and increase quality of life compared to the status quo. 
Table A.5 Results of No-Switching and Switching Models 
 
No-Switching Model 
Outcome Status Quo Patient-Centered 
Poster 
CDC Poster 
Total Unintended Pregnancies 7,828 5,773 5,891 
Mean Unintended Pregnancies Per Woman 0.78 (SD 0.03) 0.58 (SD 0.03) 0.59 (SD 0.03) 
Mean Costs per Woman $7,488.33  
(SD $566.92) 
$6,223.679 
(SD $496.52) 
$6,165.55 
(SD $501.69) 
Mean QALYs per Woman 4.66 (SD 0.05) 4.68 (SD 0.05) 4.68 (SD 0.05) 
ICER (compared to Status Quo)  DOMINANT DOMINANT 
Switching Model 
Total Unintended Pregnancies 3,486 2,384 2,472 
Mean Unintended Pregnancies Per Woman 0.35 (SD 0.01) 0.24 (SD 0.01) 0.25 (SD 0.01) 
Mean Costs per Woman $6,430.89  
(SD $491.39) 
$5,417.37 
(SD $428.08) 
$5,230.99 
(SD $407.16) 
Mean QALYs per Woman 4.67 (SD 0.07) 4.68 (SD 0.08) 4.68 (SD 0.07) 
ICER (compared to Status Quo)  DOMINANT DOMINANT 
N=10,000 runs for each model, cohort of n=10,000 
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Figures A.6 and A.7 show the ICER planes for the no-switching and switching models, 
respectively. In both models the results for the CDC and patient-centered posters have a great 
deal of overlap, indicating that there is little difference in costs and effectiveness between the 
two posters.  
 
Figure A.6 Incremental Cost-Effectiveness Ratio Plane for No-Switching Model 
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Figure A.7 Incremental Cost-Effectiveness Ratio Plane for Switching Model 
Figures A.8 and A.9 show the CEACs for the no-switching and switching models, 
respectively. In both models the CDC poster is preferred to the patient-centered poster in over 
half of the model runs. The switching model shows an increased preference for the CDC poster 
over the patient-centered poster. 
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Figure A.8 Cost-Effectiveness Acceptability Curve for No-Switching Model 
 
Figure A.9 Cost-Effectiveness Acceptability Curve for Switching Model 
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Figure A.10 shows the heat map for the bivariate sensitivity analysis. The results are very 
similar to each other even at extreme values of both costs for implementing the posters per 
woman and of intervention effectiveness. 
 
Figure A.10 Heat Map Showing Bivariate Sensitivity Analysis of Variation in Costs of 
Implementation and Effectiveness of Posters for No-Switching Model 
Finally, Table A.6 shows the results of the validity check on both models. Differences of 
greater than five percentage points are highlighted in red. The final models using primary data 
have a number of large differences between the proportion using some methods in the model 
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versus the proportion using that method in reality. The switching model also shows a number of 
large differences when it is parameterized initially with the population data. 
Table A.6 Validity Check of Final Proportions of Women Using Each Method in the Status 
Quo Branch of Both Models  
 
No-
Switching 
Model 
No-Switching 
Model Using 
Population Dataa 
Switching 
Model 
Switching Model 
Using Population 
Dataa 
Observed 
Proportions 
in 
Populationa 
No Method 6.3% 10.0% 2.0% 1.7% 10.0% 
Pill 12.9% 23.3% 11.5% 11.8% 23.3% 
Male Condom 21.7% 13.7% 11.2% 4.8% 13.7% 
Withdrawal 15.6% 4.4% 7.0% 1.4% 4.4% 
Male Sterilization 8.9% 7.4% 24.6% 16.2% 7.4% 
Female Sterilization 4.1% 22.6% 11.4% 49.4% 22.6% 
IUS/IUD 7.5% 9.3% 10.5% 9.2% 9.3% 
Injection 3.8% 4.1% 2.7% 1.8% 4.1% 
Patch 2.8% 0.5% 2.8% 0.3% 0.5% 
Ring 3.4% 1.8% 3.4% 1.2% 1.8% 
Implant 5.0% 1.2% 8.1% 1.5% 1.2% 
Fertility Awareness  7.3% 1.2% 4.4% 0.5% 1.2% 
Other Methods 0.7% 0.5% 0.4% 0.2% 0.5% 
Cells with a greater than 5 percentage point difference between the final proportion of women using that method 
and the observed proportion in the US population are highlighted in red. 
a Source: Population data is from National Survey of Family Growth 2011-2013 [96].   
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